Other and unspecified effects of external causes

ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T66-T78 Cause of death: ICD-10 — T66-T78 2 out of 7 registries used, show all original rules.	13327
4. Check minimum number of events None	13327
5. Include endpoints ST19_UNSPE_EFFEC_RADIATION ST19_EFFEC_HEAT_LIGHT ST19_HYPOTHERMIA ST19_OTHER_EFFEC_REDUCED_TEMPE ST19_EFFEC_AIR_PRESSURE_WATER_PRESSURE ST19_ASPHYXIATION ST19_EFFEC_OTHER_DEPRI ST19_MALTR_SYNDR ST19_EFFEC_OTHER_EXTER_CAUSES ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED	13327
6. Filter based on genotype QC (FinnGen only)	13327

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: S|T
Name in latin: Effectus causarum externarum aliarum sive non specificatarum

NAME	ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	ST19_UNSPE_EFFEC_RADIATION\|ST19_EFFEC_HEAT_LIGHT\|ST19_HYPOTHERMIA\|ST19_OTHER_EFFEC_REDUCED_TEMPE\|ST19_EFFEC_AIR_PRESSURE_WATER_PRESSURE\|ST19_ASPHYXIATION\|ST19_EFFEC_OTHER_DEPRI\|ST19_MALTR_SYNDR\|ST19_EFFEC_OTHER_EXTER_CAUSES\|ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T6[6-9]\|T7[0-8]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T6[6-9]\|T7[0-8]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified effects of external causes based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	13327	8457	4870
Unadjusted period prevalence (%)	2.61	2.88	2.15
Median age at first event (years)	44.72	42.52	48.53

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
11897: Matched controls
118964

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

T75.4

ICD-10 Finland

Effects of electric current

102.7

323.0

822

C01CA24

ATC

epinephrine; parenteral

15.0

323.0

3533

3260

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

4.2

323.0

2174

6009

T74.1

ICD-10 Finland

Physical abuse

41.1

323.0

1875

539

X59

ICD-10 Finland

Exposure to unspecified factor

3.8

323.0

3641

12343

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

20.3

323.0

1062

570

T68

ICD-10 Finland

Hypothermia

853.5

323.0

570

X58

ICD-10 Finland

Exposure to other specified factors

3.2

323.0

2513

9187

T78.4

ICD-10 Finland

Allergy, unspecified

79.0

323.0

5499

1279

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

415.8

323.0

1601

X57

ICD-10 Finland

Unspecified privation

9.6

323.0

725

797

T78.3

ICD-10 Finland

Angioneurotic oedema

233.1

323.0

1802

H02AB06

ATC

prednisolone; systemic

3.0

323.0

6653

35563

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

42.7

323.0

666

165

XQ800

NOMESCO Finland

Prick test

5.8

323.0

2300

4714

R06AE07

ATC

cetirizine; oral

2.4

323.0

6333

38679

W86

ICD-10 Finland

Exposure to other specified electric current

90.2

313.3

350

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

411.5

282.8

283

R03AC02

ATC

salbutamol; inhalant

2.0

265.0

6626

46479

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

262.3

4754

29411

L50.9

ICD-10 Finland

Urticaria, unspecified

5.0

254.3

882

1885

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

5.1

252.4

847

1745

L50.0

ICD-10 Finland

Allergic urticaria

6.3

242.0

681

1132

R06AX27

ATC

desloratadine; oral

2.0

227.2

3888

23156

J45.9

ICD-10 Finland

Asthma, unspecified

2.3

220.0

2334

11234

N02AX02

ATC

tramadol; systemic, rectal

1.9

216.9

4627

29806

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.9

213.4

1491

5670

W84

ICD-10 Finland

Unspecified threat to breathing

74.7

210.6

241

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

207.8

4533

29302

M79.6

ICD-10 Finland

Pain in limb

1.9

203.4

4165

26268

R06.0

ICD-10 Finland

Dyspnoea

2.1

201.6

2778

14997

S06.0

ICD-10 Finland

Concussion

2.7

200.2

1593

6537

A02BC02

ATC

pantoprazole; systemic

1.8

196.7

7024

53115

N02BE01

ATC

paracetamol; systemic, rectal

2.0

196.4

9812

83245

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

8.1

192.0

451

575

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.3

190.3

1056

3413

R51.80

ICD-10 Finland

Headache

2.2

185.2

2167

10823

N05BA04

ATC

oxazepam; oral

2.0

184.1

3012

17328

L50.8

ICD-10 Finland

Other urticaria

6.7

184.0

495

771

N05AH04

ATC

quetiapine; oral

2.1

178.6

2334

12224

H02AB07

ATC

prednisone; oral

2.4

178.6

1759

8068

Z3231

NOMESCO Finland

Registered nurse

1.9

175.1

3254

19572

AA1AD

NOMESCO Finland

CT of head and brain

2.1

174.9

2461

13288

A92

ICPC

Allergy/allergic reaction NOS

4.6

172.2

638

1448

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

171.1

2983

17500

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.5

169.3

846

2515

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

168.5

1904

9315

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

167.8

2781

15984

N06AX11

ATC

mirtazapine; oral

1.8

165.6

3678

23444

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

164.0

3159

19160

J01DB01

ATC

cefalexin; oral

1.9

163.1

9604

82277

N03AX16

ATC

pregabalin; oral

2.0

160.4

2624

14967

R06AE09

ATC

levocetirizine; oral

2.1

157.9

2065

10749

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

155.8

2995

18090

J01FF01

ATC

clindamycin; systemic

1.8

155.0

3143

19335

M54.5

ICD-10 Finland

Low back pain

1.7

148.9

3877

25796

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

148.8

2093

11204

R03DC03

ATC

montelukast; oral

2.0

146.9

2075

11119

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

9.8

146.7

306

318

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

146.2

2276

12673

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.7

141.3

674

1922

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

139.4

1726

8728

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

4.5

136.7

509

1158

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

134.4

2107

11716

N05BA01

ATC

diazepam; systemic, rectal

2.2

133.9

1564

7695

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

272.0

131.4

134

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

131.1

5736

43628

N06AB04

ATC

citalopram; systemic

1.9

131.1

2465

14631

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

131.0

1446

6929

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

129.8

1937

10552

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

125.7

2176

12520

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

125.3

4990

36888

P01AB01

ATC

metronidazole; oral, rectal

1.6

124.1

4340

30980

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

123.3

1565

7965

R53

ICD-10 Finland

Malaise and fatigue

1.8

121.5

2329

13869

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

121.2

2786

17603

J01AA02

ATC

doxycycline; systemic

1.6

121.0

8304

70074

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

120.6

1467

7323

N05CF01

ATC

zopiclone; oral

1.7

119.6

3165

20849

R60.0

ICD-10 Finland

Localized oedema

2.3

115.3

1137

5142

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

114.0

4122

29499

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.6

113.7

936

3850

R03BA02

ATC

budesonide; inhalant

1.9

111.7

2066

12106

R06AX22

ATC

ebastine; oral

1.8

111.2

2085

12276

Z71.8

ICD-10 Finland

Other specified counselling

1.7

109.5

2885

18888

M25.5

ICD-10 Finland

Pain in joint

1.7

108.2

3175

21417

Y09

ICD-10 Finland

Assault by unspecified means

12.1

107.9

202

170

R42

ICD-10 Finland

Dizziness and giddiness

1.8

107.9

2140

12823

R03BA05

ATC

fluticasone; inhalant

1.8

106.9

2168

13082

T75.1

ICD-10 Finland

Drowning and nonfatal submersion

+∞

106.4

102

T74.2

ICD-10 Finland

Sexual abuse

55.3

105.6

126

E0000UV

ATC

1.6

105.2

4479

33190

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.4

103.9

993

4412

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.5

103.8

392

903

N06AX16

ATC

venlafaxine; oral

1.9

103.7

1742

9840

R02

ICPC

Shortness of breath/dyspnoea

2.1

103.5

1317

6672

Y04.0

ICD-10 Finland

Assault by bodily force by spouse or partner

12.6

103.2

189

152

H02AB04

ATC

methylprednisolone; systemic

2.0

103.0

1582

8643

J01MA02

ATC

ciprofloxacin; systemic

1.6

102.9

3782

26992

A02BC05

ATC

esomeprazole; systemic

1.6

102.7

4077

29651

M03BX02

ATC

tizanidine; oral

1.5

102.4

6784

55504

Y96.9

ICD-10 Finland

Unspecified type of accident

5.2

102.3

333

655

R06AX13

ATC

loratadine; oral

1.8

100.3

1959

11645

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

5.8

99.9

295

517

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

99.4

5595

44016

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

99.3

2451

15670

N03AX12

ATC

gabapentin; oral

1.9

99.1

1613

8995

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

98.2

1285

6580

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

21.9

97.9

145

Y07

ICD-10 Finland

Other maltreatment

8.3

97.4

224

276

C07AB07

ATC

bisoprolol; oral

1.6

97.1

3938

28689

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

96.7

2285

14406

J01MA12

ATC

levofloxacin; systemic

1.8

96.5

1776

10333

G44.2

ICD-10 Finland

Tension-type headache

1.9

96.4

1598

8961

L03

ICPC

Low back symptom/complaint

1.7

96.1

2660

17547

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

94.8

1784

10453

XQ802

NOMESCO Finland

Epicutan test

2.9

93.4

620

2237

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

92.9

2068

12783

J01DA01

ATC

[U] cefalexin; systemic

1.5

92.9

6876

57023

L20.0

ICD-10 Finland

Besnier prurigo

2.2

92.3

1053

5076

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

92.2

1919

11609

N06AB10

ATC

escitalopram; oral

1.7

92.0

2497

16355

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

91.8

1292

6800

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

90.9

2087

13013

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

90.4

1075

5275

S18

ICPC

Laceration/cut

1.5

90.2

4069

30248

WX110

NOMESCO Finland

Local anesthesy

1.5

90.0

7983

68559

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

89.0

1190

6134

X31

ICD-10 Finland

Exposure to excessive natural cold

23.9

88.9

128

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

88.8

883

3989

R01AD09

ATC

mometasone; nasal

1.5

88.3

5057

39547

Y34

ICD-10 Finland

Unspecified event, undetermined intent

10.0

88.0

181

184

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

7.3

87.6

217

300

T63.4

ICD-10 Finland

Toxic effect: Venom of other arthropods

7.4

87.3

216

298

R74

ICPC

Upper respiratory infection acute

1.5

86.0

3652

26700

J45

ICD-10 Finland

Asthma

2.1

85.9

1118

5694

L50.3

ICD-10 Finland

Dermatographic urticaria

4.5

85.5

318

721

N06AX21

ATC

duloxetine; oral

2.0

85.4

1241

6602

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

85.4

2642

17869

J01FA06

ATC

roxithromycin; oral

1.5

84.6

4151

31311

C07AA05

ATC

propranolol; systemic

1.7

84.3

2221

14375

SPAT1254

SPAT

Administration of medicine

1.8

84.2

1595

9331

Z3226

NOMESCO Finland

Physiotherapist

1.7

83.6

1934

12051

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

83.0

4603

35599

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

82.8

1412

7968

R4110

NOMESCO Finland

Physiotherapy

1.6

82.6

2631

17904

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.2

82.6

963

4675

N06AB06

ATC

sertraline; oral

1.9

82.2

1359

7581

R60.9

ICD-10 Finland

Oedema, unspecified

2.9

81.4

536

1921

P15

ICPC

Chronic alcohol abuse

3.4

81.3

414

1239

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

81.1

6102

50097

N03AE01

ATC

clonazepam; systemic

2.5

80.9

670

2750

L27.2

ICD-10 Finland

Dermatitis due to ingested food

5.4

80.9

253

476

N05AH03

ATC

olanzapine; systemic

2.3

80.8

801

3609

R05

ICPC

Cough

1.6

80.6

2427

16262

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

80.5

1393

7894

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.9

80.4

1394

7903

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.2

80.4

441

1395

D07AA02

ATC

hydrocortisone; topical

1.8

80.2

1692

10238

ZXE00

NOMESCO Finland

One hour or less

1.5

80.0

4236

32368

J01FA10

ATC

azithromycin; systemic

1.4

79.6

6791

57054

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

79.5

1370

7749

R01AD08

ATC

fluticasone; nasal

1.5

79.3

3137

22466

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.8

78.9

356

965

P01

ICPC

Feeling anxious/nervous/tense

1.8

78.6

1530

9017

R96

ICPC

Asthma

2.1

78.3

944

4649

W19

ICD-10 Finland

Unspecified fall

2.0

77.8

1037

5322

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

77.8

808

3719

N07BB01

ATC

disulfiram; oral

2.7

77.7

582

2255

T70.0

ICD-10 Finland

Otitic barotrauma

43.9

77.4

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.5

77.4

284

636

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.1

77.3

317

790

X27

ICD-10 Finland

Contact with other specified venomous animals

40.7

77.0

M79.1

ICD-10 Finland

Myalgia

1.8

77.0

1451

8458

R50.9

ICD-10 Finland

Fever, unspecified

1.8

76.9

1523

9019

A02BC01

ATC

omeprazole; systemic

1.6

76.8

2611

18010

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

9.0

76.8

167

188

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

76.5

3334

24367

R03AC03

ATC

terbutaline; inhalant

1.8

76.5

1563

9348

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

76.3

2034

13163

T78.9

ICD-10 Finland

Adverse effect, unspecified

198.8

76.3

Y19

ICD-10 Finland

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

15.2

76.0

128

R11

ICD-10 Finland

Nausea and vomiting

2.1

75.9

932

4623

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

75.8

885

4296

N03AX09

ATC

lamotrigine; oral

2.4

75.5

686

2954

Z51.6

ICD-10 Finland

Desensitization to allergens

4.4

74.8

284

658

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

74.8

8131

71142

Z00.0

ICD-10 Finland

General medical examination

1.7

74.3

1969

12708

N05BA12

ATC

alprazolam; oral

2.0

74.0

1079

5734

N03AG01

ATC

valproic acid; systemic, rectal

2.3

73.8

764

3510

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

73.1

1400

8195

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

72.5

1306

7485

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.1

72.0

905

4532

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

71.6

2914

20909

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

71.3

2737

19379

L17

ICPC

Foot/toe symptom/complaint

1.6

70.8

2474

17126

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

70.7

3812

29028

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.5

70.5

350

1027

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

70.1

3545

26634

C03CA01

ATC

furosemide; systemic

1.6

69.9

1987

13048

C08CA01

ATC

amlodipine; oral

1.5

69.8

2700

19135

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.7

69.7

509

1944

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

69.5

604

2542

R55

ICD-10 Finland

Syncope and collapse

2.0

69.5

998

5265

M01AB05

ATC

diclofenac; systemic, rectal

1.4

69.4

6889

58765

ZXD05

NOMESCO Finland

Urgent procedure

1.5

69.4

3300

24465

Z2221

NOMESCO Finland

Medical doctor

1.5

68.9

2956

21427

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

68.8

1158

6477

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

68.7

968

5070

E000001

ATC

1.6

68.6

2292

15676

D11

ICPC

Diarrhoea

1.8

68.6

1386

8242

T78.8

ICD-10 Finland

Other adverse effects, not elsewhere classified

144.8

68.0

Y04.2

ICD-10 Finland

Assault by bodily force by friend

14.0

67.9

118

A03

ICPC

Fever

1.6

67.8

2023

13442

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

67.8

558

2278

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

67.5

2718

19410

N02AA05

ATC

oxycodone; systemic

1.9

67.5

1158

6520

J46

ICD-10 Finland

Status asthmaticus

3.3

67.1

362

1131

A02BA02

ATC

ranitidine; systemic

1.7

66.6

1714

10941

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

66.3

1497

9201

D07AB08

ATC

desonide; topical

1.8

66.3

1169

6641

XQ820

NOMESCO Finland

Exposure to medicinal substance

10.8

66.1

130

122

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

66.0

2166

14729

UJF32

NOMESCO Finland

Coloscopy

1.6

66.0

2270

15615

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.7

65.4

470

1776

N06AB03

ATC

fluoxetine; oral

1.8

65.0

1349

8076

D01

ICPC

Abdominal pain/cramps general

1.8

64.5

1288

7617

L12

ICPC

Hand/finger symptom/complaint

1.7

63.6

1527

9546

T67.0

ICD-10 Finland

Heatstroke and sunstroke

62.0

63.4

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.6

62.9

297

837

A02BC03

ATC

lansoprazole; oral

1.5

62.8

2602

18649

J02AC01

ATC

fluconazole; systemic

1.4

62.8

4285

33929

WX892

NOMESCO Finland

Monitored bed care

2.1

62.7

746

3643

WX002

NOMESCO Finland

Sedation and analgesia

1.6

62.5

1779

11649

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

62.4

4430

35318

SPAT1240

SPAT

Therapeutic discussion

1.7

62.3

1404

8610

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.1

62.0

772

3842

D07AC01

ATC

betamethasone; topical

1.4

61.9

3308

24989

R06.4

ICD-10 Finland

Hyperventilation

3.7

61.4

283

782

R07.3

ICD-10 Finland

Other chest pain

2.0

61.3

891

4715

F10.24

ICD-10 Finland

Alcohol depence active use

4.4

61.2

233

542

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

61.1

671

3160

A01

ICPC

Pain general/multiple sites

2.0

61.1

793

4014

R21

ICPC

Throat symptom/complaint

1.5

61.0

2576

18525

N05AX08

ATC

risperidone; systemic

2.0

60.9

792

4012

N30.0

ICD-10 Finland

Acute cystitis

1.7

60.8

1403

8664

S29

ICPC

Skin symptom/complaint other

1.6

60.7

1629

10494

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

60.1

749

3727

Z00.8

ICD-10 Finland

Other general examinations

2.0

60.1

820

4235

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.6

59.9

448

1732

WX290

NOMESCO Finland

Other blockade of nerve

1.4

59.9

5227

43100

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.0

59.7

841

4396

N01

ICPC

Headache

1.7

59.6

1375

8486

S80.0

ICD-10 Finland

Contusion of knee

2.1

59.4

753

3775

R52.9

ICD-10 Finland

Pain, unspecified

2.0

59.1

869

4619

R03BA01

ATC

beclometasone; inhalant

1.7

58.9

1377

8525

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

58.8

984

5479

P29

ICPC

Psychological sympt/compl other

2.0

58.7

782

4000

A46

ICD-10 Finland

Erysipelas

1.8

58.6

1155

6792

R03BB04

ATC

tiotropium bromide; inhalant

2.0

58.4

788

4049

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

57.9

2376

16944

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

57.9

722

3592

R01AD12

ATC

fluticasone furoate; nasal

1.4

57.8

3343

25564

T73.3

ICD-10 Finland

Exhaustion due to excessive exertion

44.6

57.6

SPAT1263

SPAT

Sampling

1.4

57.4

4519

36523

A04

ICPC

Weakness/tiredness general

1.7

57.2

1355

8419

Z2446

NOMESCO Finland

Social worker

2.0

57.2

783

4048

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.2

57.0

613

2860

Y88.0

ICD-10 Finland

Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use

21.7

56.9

S01.0

ICD-10 Finland

Open wound of scalp

2.1

56.9

701

3471

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

56.9

705

3498

J01FA09

ATC

clarithromycin; systemic

1.4

56.6

3308

25326

N05CD07

ATC

temazepam; oral

1.8

56.4

975

5489

N05BB01

ATC

hydroxyzine; systemic

2.0

56.3

738

3747

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.3

56.1

574

2617

SPAT1260

SPAT

Consultation of another employee

1.6

55.8

1753

11741

Y98

ICD-10 Finland

Lifestyle-related condition

14.2

55.8

EBA00

NOMESCO Finland

Extraction of tooth

1.4

55.6

3548

27590

L28

ICPC

Limited function/disability (L)

1.7

55.6

1258

7710

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

55.6

870

4725

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

55.4

990

5634

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.2

55.3

594

2770

N05AA02

ATC

levomepromazine; systemic

2.5

54.9

468

1948

XQ801

NOMESCO Finland

Intracutantest

9.7

54.7

113

117

K30

ICD-10 Finland

Functional dyspepsia

1.8

54.7

1035

5999

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.5

54.6

443

1794

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.8

54.4

1059

6197

N05CF02

ATC

zolpidem; oral

1.6

54.3

1746

11750

SPAT1283

SPAT

Restricted health certificate

1.5

54.1

2412

17477

ZY010

NOMESCO Finland

Hospital outpatient

2.1

54.1

669

3317

H01

ICPC

Ear pain/earache

1.7

53.9

1256

7758

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

53.8

1354

8546

M79.7

ICD-10 Finland

Fibromyalgia

2.6

53.7

415

1636

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

53.5

919

5158

R00.2

ICD-10 Finland

Palpitations

2.0

53.3

765

4020

Y59

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances

5.6

53.3

160

288

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

53.3

5590

47146

M01AH05

ATC

etoricoxib; oral

1.3

53.2

5885

50048

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

53.1

1023

5961

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

53.0

1448

9346

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

52.7

995

5759

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

52.2

2926

22154

N06AA09

ATC

amitriptyline; systemic

1.9

51.9

871

4847

P76

ICPC

Depressive disorder

1.9

51.4

797

4313

B18.2

ICD-10 Finland

Chronic viral hepatitis C

4.0

51.2

212

535

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

51.1

2323

16865

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.5

50.9

2326

16911

N05AX12

ATC

aripiprazole; systemic

2.2

50.8

538

2491

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.3

50.8

511

2310

N05AF03

ATC

chlorprothixene; systemic

2.8

50.6

346

1269

K02.1

ICD-10 Finland

Caries of dentine

1.3

50.6

6456

55933

SPAT1310

SPAT

Counselling related to known health issue

1.4

50.4

3306

25730

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.3

50.1

506

2290

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

50.0

1622

10919

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.7

50.0

224

606

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

49.9

3380

26445

A29

ICPC

General symptom/complaint other

1.7

49.8

1017

6034

J01EA01

ATC

trimethoprim; systemic

1.5

49.7

2405

17671

P03

ICPC

Feeling depressed

1.7

49.6

1184

7356

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

49.5

1074

6489

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.0

49.5

641

3234

D07AC13

ATC

mometasone; topical

1.4

49.3

2807

21275

D06

ICPC

Abdominal pain localized other

1.8

49.2

866

4895

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

49.2

1891

13236

L01

ICPC

Neck symptom/complaint

1.6

49.0

1383

8991

M01AE02

ATC

naproxen; oral, rectal

1.3

48.9

6122

52754

L50.1

ICD-10 Finland

Idiopathic urticaria

5.9

48.9

141

242

M54.2

ICD-10 Finland

Cervicalgia

1.9

48.8

725

3861

L15

ICPC

Knee symptom/complaint

1.5

48.7

1920

13510

K04.0

ICD-10 Finland

Pulpitis

1.7

48.5

1124

6920

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

48.5

832

4663

W69

ICD-10 Finland

Drowning and submersion while in natural water

48.5

47.9

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

47.9

740

3998

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.6

47.8

371

1467

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.3

47.8

254

787

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

47.7

865

4938

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

47.5

835

4716

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

47.4

1633

11138

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

47.4

1392

9131

X39

ICD-10 Finland

Exposure to other and unspecified forces of nature

27.2

47.2

N17

ICPC

Vertigo/dizziness

1.7

47.2

990

5918

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

47.1

4173

34044

R13

ICD-10 Finland

Dysphagia

2.1

47.0

551

2665

J01MA14

ATC

moxifloxacin; systemic

1.8

46.9

796

4440

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

3.3

46.9

251

782

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

46.5

364

1446

J30.3

ICD-10 Finland

Other allergic rhinitis

2.3

46.5

447

1976

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

46.5

3236

25370

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

46.1

841

4806

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

46.0

863

4979

R03AC13

ATC

formoterol; inhalant

2.2

46.0

471

2148

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

46.0

1053

6456

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

45.8

1136

7124

T67.1

ICD-10 Finland

Heat syncope

85.4

45.8

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

16.5

45.8

J20

ICD-10 Finland

Acute bronchitis

1.8

45.8

914

5378

Y96.8

ICD-10 Finland

Other type of accident

5.5

45.7

139

255

G47.3

ICD-10 Finland

Sleep apnoea

1.5

45.7

1836

12952

R06.2

ICD-10 Finland

Wheezing

2.2

45.6

488

2268

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

45.5

386

1601

A06AD11

ATC

lactulose; oral

1.7

45.4

1085

6736

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.4

45.2

419

1818

P74

ICPC

Anxiety disorder/anxiety state

2.1

44.7

509

2432

XQ899

NOMESCO Finland

Other assessment of skin

7.7

44.7

106

139

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

44.7

2765

21204

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.4

44.6

225

670

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.4

44.6

386

1618

SPAT1301

SPAT

No procedures

1.4

44.6

3059

23886

N06AB05

ATC

paroxetine; oral

1.9

44.3

645

3403

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

44.3

1880

13412

S22.3

ICD-10 Finland

Fracture of rib

2.0

44.2

571

2879

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

44.2

882

5189

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.4

44.0

165

380

R03AK08

ATC

formoterol and beclometasone; inhalant

2.4

44.0

392

1670

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.2

43.9

469

2180

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

43.5

673

3635

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

43.3

5814

50213

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

43.3

887

5258

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

42.9

6211

54183

SPAT1307

SPAT

Psychosocial counselling and guidance

1.7

42.9

868

5125

T70.3

ICD-10 Finland

Caisson disease [decompression sickness]

+∞

42.7

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

42.6

2587

19747

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

42.6

2849

22116

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

42.4

663

3593

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

42.3

523

2587

SGA01

NOMESCO Finland

Tooth opening as first aid

1.5

42.3

1714

12096

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

42.3

1502

10298

R52.2

ICD-10 Finland

Other chronic pain

2.5

42.2

356

1474

D10

ICPC

Vomiting

1.8

42.2

790

4551

R07.0

ICD-10 Finland

Pain in throat

1.9

42.1

699

3867

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

42.1

1041

6517

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

41.9

2028

14835

P19

ICPC

Drug abuse

3.9

41.9

180

471

T75.2

ICD-10 Finland

Effects of vibration

112.9

41.7

L16

ICPC

Ankle symptom/complaint

1.7

41.7

1029

6438

K10.3

ICD-10 Finland

Alveolitis of jaws

2.0

41.6

529

2648

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

41.6

1504

10349

F61.0

ICD-10 Finland

Mixed personality disorders

3.0

41.5

251

850

B01AB05

ATC

enoxaparin; parenteral

1.4

41.5

2515

19177

J45.8

ICD-10 Finland

Mixed asthma

2.5

41.5

332

1337

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

41.4

1206

7882

L02

ICPC

Back symptom/complaint

1.7

41.4

953

5847

SPAT1312

SPAT

General health counselling

1.3

41.3

3449

27730

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

41.2

509

2518

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.2

41.0

439

2042

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

3.0

41.0

248

840

N05BA02

ATC

chlordiazepoxide; systemic

2.9

41.0

255

882

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.2

40.8

432

1998

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

40.8

790

4599

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

40.8

849

5056

P16

ICPC

Acute alcohol abuse

3.3

40.7

212

648

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

40.6

650

3550

R03AC12

ATC

salmeterol; inhalant

2.3

40.5

407

1839

WZC30

NOMESCO Finland

Teaching

1.6

40.5

1143

7409

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.5

40.4

149

338

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.4

40.3

361

1540

K08.80

ICD-10 Finland

Toothache NOS

1.7

40.3

851

5091

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

40.1

540

2766

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.2

40.1

410

1868

A28

ICPC

Limited function/disability NOS

1.7

40.0

990

6192

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

40.0

1944

14218

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

39.9

637

3478

T67.3

ICD-10 Finland

Heat exhaustion, anhydrotic

205.6

39.8

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

5.5

39.8

120

219

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

39.7

562

2936

Y94.0

ICD-10 Finland

Accident at home

3.2

39.7

212

661

S21

ICPC

Skin texture symptom/complaint

1.6

39.4

1106

7155

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

39.3

3862

31758

-1

NOMESCO Finland

1.3

39.3

3769

30886

ZXA00

NOMESCO Finland

Right side

1.4

39.3

2215

16654

T90

ICPC

Diabetes non-insulin dependent

1.5

39.1

1639

11629

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

39.1

1245

8308

R05

ICD-10 Finland

Cough

1.5

39.1

1752

12603

R03BA08

ATC

ciclesonide; inhalant

1.7

39.0

789

4654

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

38.8

963

6032

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.0

38.7

543

2824

B02AA02

ATC

tranexamic acid; systemic

1.5

38.7

1419

9781

Z2445

NOMESCO Finland

Psychologist

2.0

38.6

522

2678

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.1

38.3

153

375

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

38.2

1277

8617

WQ000

NOMESCO Finland

Hyposensibilisation

4.9

38.1

128

264

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

38.1

2704

21130

SPAT1211

SPAT

Application of soft bandage

1.7

37.9

855

5211

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

37.8

507

2592

S20.2

ICD-10 Finland

Contusion of thorax

2.1

37.8

458

2247

W10

ICD-10 Finland

Fall on and from stairs and steps

2.1

37.6

468

2321

N06AX12

ATC

bupropion; oral

1.8

37.6

738

4310

J05AB01

ATC

aciclovir; systemic

1.4

37.3

1979

14694

A10BA02

ATC

metformin; oral

1.4

37.3

2003

14908

Z72.2

ICD-10 Finland

Drug use

4.9

37.0

124

255

R29

ICPC

Respiratory symptom/complaint other

1.8

37.0

624

3471

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

36.8

1973

14672

SPAT1265

SPAT

Breathalyser

4.1

36.8

147

361

F41.00

ICD-10 Finland

Moderate panic disorder

2.8

36.7

244

880

P06

ICPC

Sleep disturbance

1.6

36.6

1004

6452

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

36.6

3290

26635

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.0

36.6

220

746

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

36.5

454

2253

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

36.5

522

2737

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

36.5

838

5131

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.2

36.5

389

1806

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

36.4

950

6024

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.6

36.4

170

478

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.4

36.4

317

1333

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.9

36.3

597

3290

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

36.2

629

3533

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.4

36.2

185

558

L08

ICPC

Shoulder symptom/complaint

1.5

36.2

1604

11499

X48

ICD-10 Finland

Accidental poisoning by and exposure to pesticides

60.2

36.1

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.1

36.1

415

1991

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

36.0

757

4517

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

36.0

598

3308

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

35.9

357

1605

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

35.8

585

3219

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

35.7

719

4235

XF404

NOMESCO Finland

Ambulatory ECG

1.7

35.6

751

4487

U02

ICPC

Urinary frequency/urgency

1.5

35.6

1174

7891

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

35.5

2928

23377

R01AD05

ATC

budesonide; nasal

1.7

35.4

751

4494

K08.3

ICD-10 Finland

Retained dental root

1.9

35.4

582

3211

ZXA05

NOMESCO Finland

Left side

1.4

35.3

2041

15374

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

35.3

573

3146

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

35.2

610

3425

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

35.1

602

3364

N05BE01

ATC

buspirone; oral

2.4

35.1

307

1298

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

35.0

1452

10264

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

35.0

1367

9540

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

35.0

667

3863

N06AX05

ATC

trazodone; oral

2.5

34.9

281

1136

KMAK

NOMESCO Finland

1.3

34.9

5635

49274

Y94.8

ICD-10 Finland

Other leisure activity accident

2.4

34.9

295

1223

WZA90

NOMESCO Finland

Other doctors statement

1.4

34.8

2388

18510

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

34.8

685

4004

X30

ICD-10 Finland

Exposure to excessive natural heat

78.3

34.8

A11

ICPC

Chest pain NOS

1.8

34.7

615

3475

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

34.7

493

2579

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

34.6

607

3420

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.3

34.5

181

558

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.3

34.5

342

1537

N76.0

ICD-10 Finland

Acute vaginitis

1.7

34.1

701

4152

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

34.1

623

3557

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

34.0

659

3835

F29

ICPC

Eye symptom/complaint other

1.7

33.9

773

4720

W99

ICD-10 Finland

Exposure to other and unspecified man-made environmental factors

7.3

33.7

113

P99

ICPC

Psychological disorders other

2.3

33.7

336

1513

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

33.6

536

2921

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

33.6

536

2922

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.1

33.6

413

2040

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

33.5

575

3217

SPAT1252

SPAT

Overall medication plan or its review

1.9

33.4

531

2894

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

33.4

1059

7050

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.3

33.3

307

1332

L11

ICPC

Wrist symptom/complaint

1.7

33.3

808

5023

N06AA12

ATC

doxepin; systemic

2.0

33.3

431

2175

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

5.9

33.3

163

R06AX26

ATC

fexofenadine; oral

1.7

33.2

697

4155

XF402

NOMESCO Finland

ECG with work load test

1.7

33.1

800

4964

Z72.1

ICD-10 Finland

Alcohol use

3.5

33.1

158

453

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.3

33.0

318

1407

J01MA06

ATC

norfloxacin; oral

1.5

33.0

1140

7738

Y87.1

ICD-10 Finland

Sequelae of assault

20.5

33.0

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

32.9

2485

19533

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.7

32.9

113

240

D02

ICPC

Abdominal pain epigastric

1.8

32.9

562

3139

T67.5

ICD-10 Finland

Heat exhaustion, unspecified

74.3

32.8

A01AB09

ATC

miconazole; local oral

1.7

32.8

759

4654

Z25

ICPC

Assault/harmful event problem

3.9

32.8

139

361

R10.0

ICD-10 Finland

Acute abdomen

2.2

32.8

330

1493

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.5

32.8

1189

8158

Z01.2

ICD-10 Finland

Dental examination

1.3

32.7

4384

37332

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

32.5

646

3785

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

32.5

816

5116

N05BA06

ATC

lorazepam; systemic, sublingual

2.0

32.5

420

2117

SPAT1216

SPAT

Assessment of functional ability

1.5

32.4

1111

7526

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

32.4

4103

34678

R4120

NOMESCO Finland

Occupational therapy

1.8

32.4

582

3307

K92.0

ICD-10 Finland

Haematemesis

2.7

32.3

222

819

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

2.1

31.9

357

1695

S10

ICPC

Boil/carbuncle

1.9

31.8

503

2734

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.0

31.7

424

2167

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.9

31.7

449

2347

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.5

31.7

262

1075

UKC02

NOMESCO Finland

Cystoscopy

1.5

31.5

1116

7618

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.5

31.4

248

994

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.2

31.3

343

1614

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

6.5

31.3

126

D07AD01

ATC

clobetasol; topical

1.5

31.3

1308

9246

T71

ICD-10 Finland

Asphyxiation

+∞

31.3

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.5

31.2

250

1008

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

31.2

1593

11705

Y08.8

ICD-10 Finland

Assault by other specified means by other known person

22.6

31.2

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

31.2

405

2046

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

31.2

449

2361

ZXA10

NOMESCO Finland

Bilateral

1.4

31.1

1555

11381

M54.3

ICD-10 Finland

Sciatica

1.8

31.0

512

2824

E000003

ATC

1.9

31.0

469

2508

E000002

ATC

1.5

31.0

1169

8087

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

30.8

1040

7017

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

30.8

1010

6770

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.6

30.7

910

5953

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

6.6

30.7

122

SPAT1262

SPAT

Handing over of treatment supplies

1.4

30.6

1420

10249

N06AX03

ATC

mianserin; oral

2.0

30.5

406

2071

J01CA04

ATC

amoxicillin; systemic

1.3

30.5

9143

85559

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

30.5

7249

65904

SPAT1104

SPAT

Monitoring of emergency patient

1.8

30.4

554

3160

J04.0

ICD-10 Finland

Acute laryngitis

2.0

30.4

392

1975

R51

ICD-10 Finland

Headache

1.8

30.4

557

3181

U01

ICPC

Dysuria/painful urination

1.7

30.4

710

4364

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

30.3

747

4663

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

30.3

597

3492

H92.0

ICD-10 Finland

Otalgia

1.8

30.2

522

2927

SPAT1153

SPAT

Removal of sutures

1.3

30.1

2663

21388

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.5

30.1

1072

7324

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

30.0

521

2925

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

30.0

823

5279

M02AA07

ATC

piroxicam; topical

1.3

30.0

2963

24171

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.8

30.0

505

2806

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

29.9

1008

6798

Z01.9

ICD-10 Finland

Special examination, unspecified

1.9

29.8

475

2589

Z50.1

ICD-10 Finland

Other physical therapy

1.9

29.8

463

2503

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

29.5

4168

35589

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

29.5

473

2586

J01FA01

ATC

erythromycin; systemic

1.4

29.5

1541

11363

SPAT1227

SPAT

Substance abuse rehabilitation

4.3

29.5

112

264

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

5.8

29.4

145

H66.9

ICD-10 Finland

Otitis media, unspecified

1.7

29.4

679

4162

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.1

29.3

359

1771

S01

ICPC

Pain/tenderness of skin

2.0

29.2

391

2000

SPAT1234

SPAT

Support of social functional capacity

2.0

29.2

397

2043

N89

ICPC

Migraine

1.9

29.2

420

2209

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

29.1

757

4790

W52

ICD-10 Finland

Crushed, pushed or stepped on by crowd or human stampede

2.7

29.0

207

784

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

28.9

1481

10879

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.5

28.9

140

408

W64

ICD-10 Finland

Exposure to other and unspecified animate mechanical forces

4.0

28.8

118

298

N06BA04

ATC

methylphenidate; oral

2.2

28.8

313

1468

R05FB02

ATC

cough suppressants and expectorants

1.3

28.8

3182

26320

S70.0

ICD-10 Finland

Contusion of hip

2.3

28.8

273

1201

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.4

28.8

250

1054

SPAT1272

SPAT

Drug screening

5.4

28.7

161

L50

ICD-10 Finland

Urticaria

2.8

28.7

189

681

M54

ICD-10 Finland

Dorsalgia

1.5

28.7

1067

7351

ZX120

NOMESCO Finland

Intravenous

1.6

28.6

782

5010

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

28.6

790

5078

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.9

28.6

120

310

P18

ICPC

Medication abuse

4.4

28.5

105

240

S63.5

ICD-10 Finland

Sprain and strain of wrist

2.0

28.5

366

1840

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.7

28.5

637

3867

T00.9

ICD-10 Finland

Multiple superficial injuries, unspecified

5.0

28.4

188

N05AN01

ATC

lithium; oral

2.3

28.4

274

1217

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

28.4

638

3878

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

28.3

1808

13793

A08

ICPC

Swelling

2.1

28.3

321

1533

R12

ICD-10 Finland

Heartburn

1.7

28.2

643

3923

L29

ICPC

Musculoskeletal sympt/complt other

1.7

28.2

644

3933

S04

ICPC

Lump/swelling localized

1.6

28.1

858

5648

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

4.6

28.1

100

221

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

4.6

28.1

100

221

A99

ICPC

Disease/condition unspecnature/site

1.7

28.1

666

4111

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.0

28.1

380

1953

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.6

28.0

205

788

SPAT1058

SPAT

PEF monitoring instruction

1.6

28.0

699

4374

T75.0

ICD-10 Finland

Effects of lightning

282.2

27.7

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

27.7

1002

6857

WX320

NOMESCO Finland

Spinalanesthesy

1.4

27.7

1855

14258

M04AA01

ATC

allopurinol; systemic

1.6

27.7

766

4922

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.6

27.7

850

5604

E66.8

ICD-10 Finland

Other obesity

1.8

27.7

518

2979

R09

ICPC

Sinus symptom/complaint

1.6

27.6

785

5083

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

27.5

1054

7307

D09

ICPC

Nausea

1.8

27.5

504

2881

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

27.4

841

5543

R51.81

ICD-10 Finland

Facial pain NOS

2.4

27.4

229

947

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.5

27.3

882

5884

C09AA05

ATC

ramipril; oral

1.4

27.2

1591

11952

H57.1

ICD-10 Finland

Ocular pain

2.1

27.2

322

1566

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

27.2

3744

31782

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

27.1

617

3761

F43.01

ICD-10 Finland

Acute stress reaction moderate

2.7

27.1

195

740

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

27.1

526

3060

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

27.1

552

3263

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

27.0

890

5968

N06AX26

ATC

vortioxetine; oral

1.7

27.0

602

3654

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

26.9

363

1863

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.4

26.9

240

1026

K04.08

ICD-10 Finland

Other specified pulpit

1.6

26.8

695

4392

R03DA04

ATC

theophylline; systemic, rectal

1.9

26.8

376

1959

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

26.8

1909

14813

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

26.6

343

1728

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

26.6

1390

10238

M01AX17

ATC

nimesulide; oral

1.3

26.5

1832

14141

N07BA03

ATC

varenicline; oral

1.8

26.5

499

2877

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.2

26.5

263

1184

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.2

26.5

276

1272

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

26.4

615

3773

S00.0

ICD-10 Finland

Superficial injury of scalp

2.6

26.4

202

796

C07AB02

ATC

metoprolol; systemic

1.4

26.4

1353

9930

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

26.4

463

2611

J01DA06

ATC

[U] cefuroxime; systemic

1.4

26.4

1321

9653

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

26.3

2427

19550

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.8

26.3

169

601

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.8

26.2

448

2501

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

26.2

815

5390

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

26.1

1083

7629

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

3.5

26.1

124

356

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.3

26.1

241

1048

C03DA01

ATC

spironolactone; oral

1.6

26.0

703

4492

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

26.0

637

3962

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

26.0

355

1828

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.0

26.0

329

1645

S01GX02

ATC

levocabastine; ophthalmic

1.7

26.0

614

3784

J01CA08

ATC

pivmecillinam; oral

1.3

26.0

3840

32827

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.0

25.8

330

1660

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.1

25.8

295

1415

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.4

25.7

224

946

T74.9

ICD-10 Finland

Maltreatment syndrome, unspecified

261.2

25.7

W94

ICD-10 Finland

Exposure to high and low air pressure and changes in air pressure

261.2

25.7

J05AB11

ATC

valaciclovir; oral

1.4

25.7

1139

8128

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

25.6

1147

8203

H03AA01

ATC

levothyroxine sodium; systemic

1.3

25.5

2023

15943

N05AB03

ATC

perphenazine; systemic, rectal

2.0

25.4

333

1689

K04.09

ICD-10 Finland

Pulpit UNS

1.8

25.3

427

2374

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

25.3

776

5117

J01DC02

ATC

cefuroxime; systemic

1.7

25.3

550

3314

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.5

25.2

917

6279

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

25.2

669

4255

E000006

ATC

1.6

25.2

625

3903

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.7

25.2

492

2871

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

25.1

912

6246

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

25.0

1144

8213

A97

ICPC

No disease

1.4

24.9

1384

10295

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

24.9

454

2592

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

24.9

287

1383

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

5.6

24.9

131

X12

ICD-10 Finland

Contact with other hot fluids

4.0

24.8

100

250

TQW80

NOMESCO Finland

Local dermatologic skincare

2.3

24.8

241

1077

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3011897) Casein IgE Ab [Units/volume] in Serum

294

209

14.36

323.31

1.4

1.2

u/ml

14.8

3.6

1.00

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1138

3362

3.61

321.29

1.7

1.8

g/l

1.2

1.42

1048

3218

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

292

107

27.88

307.65

1.1

u/ml

0.4

0.3

0.22

174

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1134

3259

3.71

307.65

1.7

1.8

g/l

0.2

0.93

1037

3115

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

608

271

23.46

307.65

1.3

1.2

111.5

111.3

0.03

555

238

(3019420) Tryptase [Mass/volume] in Serum or Plasma

700

499

14.75

307.65

1.5

ug/l

7.2

7.3

0.02

606

455

(3005322) IgE [Units/volume] in Serum or Plasma

1918

7560

2.80

307.65

1.5

1.3

u/ml

383.9

220.0

4.84

1840

6985

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

318

222

14.65

307.65

1.2

1.1

u/ml

11.3

7.7

0.36

238

159

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

628

302

21.77

307.65

1.3

1.2

g/l

0.3

1.60

489

243

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4533

27634

1.97

272.30

2.6

2.1

u/l

230.2

207.6

0.61

4313

26028

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7147

50980

1.87

261.39

6.2

5.9

umol/l

10.5

11.1

2.84

6768

48154

(3022096) Basophils/100 leukocytes in Blood

6879

48804

1.85

252.67

6.7

6.2

0.6

0.7

4.68

6477

45702

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

202

112

18.30

252.47

1.0

u/ml

0.3

0.1

1.17

118

(3013826) Glucose [Moles/volume] in Serum or Plasma

7905

58628

1.86

250.72

5.8

4.5

mmol/l

6.5

0.03

7482

53859

(3013115) Eosinophils [#/volume] in Blood

7600

55736

1.85

249.37

6.9

6.3

e9/l

0.2

7.68

6788

49387

(3006315) Basophils [#/volume] in Blood

7399

53819

1.84

249.29

6.6

6.0

e9/l

0.0

1.09

6494

46945

(3019069) Monocytes/100 leukocytes in Blood

7062

50699

1.84

247.68

6.9

6.4

8.2

8.4

4.73

6677

47737

(3006504) Eosinophils/100 leukocytes in Blood

7031

50415

1.84

247.52

6.6

6.2

2.9

2.8

1.80

6609

47186

(3001604) Monocytes [#/volume] in Blood

7368

53620

1.84

246.84

6.6

6.0

e9/l

0.6

2.51

6467

46810

(3013650) Neutrophils [#/volume] in Blood by Automated count

8181

61714

1.84

241.29

9.6

9.0

e9/l

4.2

4.0

14.16

7221

54120

(3002030) Lymphocytes/100 leukocytes in Blood

7229

52633

1.82

238.39

6.7

6.2

28.7

29.1

3.48

6824

49365

(3018010) Neutrophils/100 leukocytes in Blood

7127

51870

1.80

233.30

6.5

6.0

56.8

56.4

1.82

6740

48816

(3019198) Lymphocytes [#/volume] in Blood

7522

55639

1.81

233.09

6.6

6.0

e9/l

2.0

1.27

6758

49487

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

193

118

16.58

229.95

1.1

1.0

u/ml

5.2

0.4

1.00

114

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

200

131

15.48

229.94

1.1

u/ml

4.3

1.5

1.25

153

103

(42870588) Differential panel, method unspecified - Blood

5320

35670

1.82

227.45

6.3

6.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9720

78221

1.90

223.77

8.3

7.1

u/l

76.6

76.5

0.05

9246

73780

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

186

113

16.68

222.31

1.1

1.0

u/ml

0.8

0.2

1.19

109

(3023368) Bacteria identified in Blood by Culture

3918

24019

1.89

222.17

4.7

4.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

177

18.11

220.25

1.1

1.0

u/ml

0.8

0.1

1.68

103

(3012494) Peanut IgE Ab [Units/volume] in Serum

303

400

7.73

215.38

1.1

u/ml

16.2

10.8

0.21

226

223

(3011841) English Walnut IgE Ab [Units/volume] in Serum

191

131

14.78

214.17

1.1

u/ml

6.9

2.7

0.75

147

101

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6477

46869

1.74

206.52

7.4

6.6

mmol/l

1.2

1.63

5543

39662

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5056

34144

1.77

205.22

4.0

3.1

ng/l

72.1

60.2

0.11

2988

19850

(3002582) Erythrocytes [#/volume] in Urine

4513

29627

1.79

200.72

3.6

3.1

e6/l

60.1

78.0

0.38

3594

22410

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5947

42290

1.73

199.48

6.9

6.0

mmol/l

1.2

3.19

5446

38558

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4694

31298

1.77

197.09

3.1

2.5

u/l

53.8

57.6

5.48

4345

28992

(3013707) Erythrocyte sedimentation rate by Westergren method

9544

78174

1.78

185.19

4.6

3.8

mm/h

11.3

10.5

6.15

8938

72947

(3018095) Leukocytes [#/volume] in Urine

5147

35781

1.71

182.61

4.3

3.5

e6/l

82.8

83.4

0.01

3787

24403

(3030467) Casts [#/volume] in Urine by Automated count

4127

27101

1.76

178.80

3.5

3.0

e6/l

0.3

0.4

0.90

3184

20103

(3032080) INR in Blood by Coagulation assay

5142

35999

1.70

175.91

8.2

7.5

inr

1.1

1.2

4.86

1756

11048

(3021589) Normoblasts [#/volume] in Blood

6439

47835

1.67

175.55

10.6

9.0

e9/l

0.0

2.81

5327

39192

(36304419) Bacteria [Presence] in Urine

4073

26822

1.75

173.67

3.5

2.9

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3633

23265

1.77

170.17

2.0

1.8

mg/l

1.0

1.1

1.07

2658

17285

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2865

17262

1.84

163.56

4.1

3.4

ng/l

195.4

498.1

4.27

1852

11875

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

128

19.00

163.02

1.0

u/ml

1.6

2.0

0.09

(3031040) Bacteria [#/volume] in Urine by Automated count

8615

69727

1.67

161.99

5.4

4.1

e6/l

1350.4

1394.9

0.03

129

854

(3037467) Urinalysis macro (dipstick) panel - Urine

8983

73517

1.68

161.62

5.0

4.0

—

(3000850) Epithelial cells [#/volume] in Urine

3244

20452

1.77

158.47

2.9

2.5

e6/l

7.0

6.3

1.80

2890

17844

(40758558) Short blood count panel - Blood

3970

26494

1.71

158.32

6.8

6.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

12059

108086

2.22

158.00

19.0

13.1

mmol/l

139.5

139.6

9.71

11861

105247

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2506

14618

1.88

157.92

2.0

1.8

—

(3026782) Osmolality of Urine

3050

18915

1.79

157.45

3.0

2.6

mosm/kgh2o

531.2

547.9

3.40

2664

16089

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4984

35462

1.65

154.68

3.5

3.2

u/l

34.4

32.9

0.35

4699

33719

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

12219

110301

2.30

153.91

18.3

12.0

mg/l

20.3

21.8

5.99

10357

85312

(3023103) Potassium [Moles/volume] in Serum or Plasma

12067

108430

2.19

153.03

19.2

13.2

mmol/l

3.9

9.12

11849

105338

(3024561) Albumin [Mass/volume] in Serum or Plasma

5609

41296

1.62

150.40

5.1

4.8

g/l

36.0

36.2

2.47

5245

38455

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

132

14.64

147.50

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

790

2969

2.77

145.34

4.4

2.6

—

(3033658) Prothrombin time (PT) actual/Normal

3806

25614

1.68

144.42

4.5

4.0

93.5

92.6

1.39

3703

24948

(3027231) Wheat IgE Ab [Units/volume] in Serum

205

274

7.58

144.08

1.1

u/ml

2.4

2.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

129

14.15

141.44

1.0

u/ml

1.2

1.4

0.07

(3016031) Almond IgE Ab [Units/volume] in Serum

119

15.19

135.71

1.1

u/ml

0.8

1.1

0.25

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

113

16.04

132.63

1.0

u/ml

18.1

22.8

0.24

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5121

37748

1.58

131.12

2.1

1.9

pmol/l

95.6

97.2

1.74

2824

20022

(3018418) pH of Serum or Plasma

3957

27529

1.62

128.71

4.3

4.0

7.4

0.36

820

5336

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

11233

99894

1.79

126.27

15.4

10.8

ml/min/173m2

89.6

88.0

10.99

9659

81418

(3026008) Bacteria identified in Urine by Culture

4117

29034

1.60

126.03

3.3

2.8

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

103

17.29

125.54

1.1

1.0

u/ml

0.9

0.2

1.30

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2508

15626

1.75

123.47

2.4

1.7

1.5

1.4

17.35

2181

13993

(3014111) Lactate [Moles/volume] in Serum or Plasma

1467

7795

1.99

119.56

7.4

7.5

mmol/l

1.4

1.3

1.70

1411

7497

(3012544) pH of Venous blood

1579

8619

1.94

118.97

4.5

7.4

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

111

13.48

118.42

1.4

1.3

u/ml

10.8

2.0

0.91

(3002032) Base excess in Venous blood by calculation

1531

8302

1.95

117.53

4.6

mmol/l

1.7

1.8

0.27

1245

6727

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1536

8348

1.95

117.11

4.6

4.5

kpa

5.9

5.8

0.43

1482

8104

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

109

13.56

116.70

1.1

1.0

u/ml

7.9

0.00

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1681

9475

1.89

114.64

2.6

2.5

u/l

74.8

42.6

0.35

1429

8119

(3037522) Nuclear Ab [Titer] in Serum

2453

15491

1.72

113.98

1.5

1.4

titre

538.5

541.6

0.02

467

3049

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9876

85737

1.59

112.11

4.6

4.0

pmol/l

14.5

14.6

2.07

9169

78972

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1715

9808

1.86

111.53

1.9

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8983

76447

1.54

110.47

4.0

2.9

u/l

48.2

41.9

8.09

8494

72329

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2281

14259

1.72

109.51

2.2

2.4

29.8

29.7

0.69

2213

13813

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2417

15371

1.70

108.88

3.1

2.8

e6/l

4.1

3.0

3.74

1312

8108

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1715

9896

1.84

108.16

1.9

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

11184

100409

1.71

107.83

5.5

4.6

mu/l

2.0

0.15

10519

93635

(3020191) Ethanol [Moles/volume] in Serum or Plasma

345

944

3.73

107.71

1.9

1.5

promille

1.6

1.3

2.56

250

706

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2377

15149

1.69

105.89

3.8

3.7

mmol/l

0.8

1.38

2225

14205

(3007853) Bacteria identified in Skin by Aerobe culture

2007

12235

1.75

104.96

1.9

1.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

4355

32180

1.52

103.68

3.2

mmol/l

2.3

2.4

1.98

3860

28446

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1898

11602

1.74

97.72

2.7

2.9

umol/l

7.3

7.4

0.10

1590

9991

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

694

2976

2.41

96.52

2.4

ug/l

596.5

527.7

0.22

641

2754

(3000991) Gas panel - Venous blood

1387

7760

1.88

95.77

9.4

8.9

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1734

10424

1.76

94.42

17.2

20.5

inr

1.2

1.3

2.20

308

1609

(3013512) EKG study

3561

25625

1.53

93.93

3.9

3.4

—

(3044640) Blood type and Crossmatch panel - Blood

4354

32705

1.49

93.38

2.6

2.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3329

23680

1.54

92.32

1.5

1.4

g/l

2.3

0.41

1995

14932

(3011288) Drugs identified in Urine by Screen method

968

4854

2.07

91.66

5.5

2.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

1256

6900

1.91

91.55

4.1

4.0

kpa

4.7

0.11

1204

6679

(3021960) Folate [Moles/volume] in Serum or Plasma

2969

20667

1.56

90.47

1.6

1.5

nmol/l

19.5

20.4

2.99

2576

17973

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

260

664

3.97

89.54

1.7

1.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2459

16419

1.61

89.43

3.0

2.6

e6/l

1.3

1.1

0.41

1361

9119

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

20.10

88.80

1.1

—

(3042936) Bacteria identified in Isolate by Culture

2119

13678

1.65

88.21

2.2

2.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1060

5573

1.98

87.86

3.9

2.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

632

2720

2.39

87.06

1.1

u/ml

4.9

6.2

1.39

431

1482

(3036312) Salmon IgE Ab [Units/volume] in Serum

13.04

86.92

1.2

1.0

u/ml

1.4

1.5

0.04

(40768797) Stomach Pathology biopsy report

2075

13376

1.65

86.69

1.3

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2357

15694

1.61

86.38

1.8

1.7

nmol/l

1119.0

1175.0

2.26

1812

12056

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3103

22021

1.53

85.95

3.0

2.9

ng/l

1176.0

1196.0

0.09

2575

18474

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3699

27286

1.49

84.98

1.9

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

6449

52845

1.43

84.70

5.5

4.6

estimate

0.0

0.16

1471

10314

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

10.64

84.56

1.1

1.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1756

10902

1.70

84.49

7.9

7.3

mmol/l

104.4

104.6

0.73

1705

10685

(3009261) Glucose [Presence] in Urine by Test strip

6489

53271

1.43

84.12

4.1

3.4

estimate

0.0

0.14

1433

10045

(4198724)

271

746

3.69

83.86

2.6

—

(3035350) Ketones [Presence] in Urine by Test strip

6425

52692

1.42

83.54

4.0

3.3

estimate

0.0

1.54

1422

9996

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

282

801

3.58

83.28

1.2

1.3

u/ml

1.2

1.0

0.08

338

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3691

27304

1.49

83.27

1.4

1.3

u/ml

1.6

1.7

0.17

985

7599

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1644

10148

1.71

80.52

2.3

2.2

nmol/l

362.8

373.9

0.98

1526

9342

(3022948) Iron [Moles/volume] in Serum or Plasma

2258

15120

1.59

80.15

2.6

2.5

umol/l

12.9

13.7

5.71

2073

14124

(3010726) Horse dander IgE Ab [Units/volume] in Serum

592

2587

2.35

78.68

1.1

u/ml

3.6

2.3

0.97

180

691

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2717

19094

1.53

77.55

1.4

1.3

iu/ml

26.9

30.0

0.54

742

5877

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

660

3046

2.23

77.06

1.2

1.1

u/ml

2.0

1.7

0.36

394

1267

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3396

25028

1.48

76.89

2.5

2.2

mg/l

2.8

0.76

2931

21529

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2586

18016

1.54

76.72

1.3

u/ml

8.9

11.0

0.90

914

7409

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5397

43382

1.41

76.08

2.6

2.3

nmol/l

73.0

2133.6

0.50

4943

39835

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2081

13821

1.60

76.07

2.6

2.5

g/l

2.4

0.20

1889

12880

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1182

6764

1.82

75.07

1.6

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

908

4771

1.97

75.03

4.8

5.1

mmol/l

24.2

24.1

0.50

824

4337

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2985

21539

1.50

74.71

2.6

2.2

—

(3016879) Cocaine [Presence] in Urine

1168

6689

1.82

73.94

3.9

2.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

583

2603

2.30

73.67

1.1

u/ml

1.4

1.2

0.23

375

1162

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1089

6116

1.85

73.43

8.5

8.2

mmol/l

24.8

24.7

0.42

1078

6078

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2748

19553

1.51

73.42

2.5

2.1

—

(3003396) Base excess in Arterial blood by calculation

1548

9662

1.68

72.22

8.3

7.5

mmol/l

0.8

0.9

0.38

1228

7444

(3016502) Oxygen saturation in Arterial blood

1403

8541

1.72

71.79

8.7

8.0

95.3

95.9

2.20

1362

8195

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1925

12730

1.60

71.22

2.7

2.6

22.2

23.4

3.09

1665

11006

(3028300) Cannabinoids [Presence] in Urine

1229

7275

1.76

69.37

3.9

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

1220

7209

1.76

69.29

3.8

2.0

—

(3048689) Calprotectin [Mass/mass] in Stool

2246

15481

1.54

69.11

2.5

ug/g

113.5

123.0

0.68

1758

12184

(3009343) pH of Capillary blood

1043

5899

1.83

68.59

4.5

4.1

7.4

0.45

162

705

(3023511) Choriogonadotropin [Units/volume] in Urine

754

3834

2.02

68.25

1.6

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1051

5970

1.83

68.14

4.5

4.1

kpa

5.2

5.1

1.00

992

5569

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

990

5521

1.86

68.10

1.6

1.5

—

(3027008) Opiates [Presence] in Urine

1221

7261

1.75

67.75

3.8

1.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6192

51586

1.37

67.52

3.3

2.9

ug/l

106.3

101.6

0.78

5767

48487

(3027801) Oxygen [Partial pressure] in Arterial blood

1527

9656

1.66

67.46

8.4

7.5

kpa

12.2

12.9

6.12

1468

9200

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6048

50209

1.37

67.35

4.4

3.9

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1527

9662

1.66

67.29

8.4

7.5

kpa

5.1

0.35

1469

9209

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1010

5719

1.83

66.09

4.4

4.1

mmol/l

1.8

1.5

1.48

730

4161

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1302

7939

1.71

65.94

9.1

8.3

g/l

123.8

122.1

2.31

1265

7632

(3044889) 12 lead EKG panel

7976

69338

1.37

65.82

3.7

3.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3302

24861

1.44

64.78

2.5

2.2

—

(3027944) Amphetamines [Presence] in Urine

1195

7165

1.73

64.25

3.6

1.9

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1829

12220

1.58

64.20

6.5

6.3

mmol/l

1.1

0.44

1733

11460

(3015076) Soybean IgE Ab [Units/volume] in Serum

258

821

3.18

63.67

1.1

1.0

u/ml

0.5

1.2

0.62

125

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

912

5072

1.86

63.15

1.7

1.6

—

(3000492) Spirometry study

1656

10870

1.60

62.58

1.5

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

275

937

2.98

60.34

1.3

1.1

u/ml

10.6

1.5

1.82

169

281

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12273

116163

1.71

60.07

12.1

9.3

u/l

27.7

26.7

4.23

11998

112516

(3009508) Creatinine [Moles/volume] in Urine

3773

29395

1.40

60.02

3.8

3.2

mmol/l

7.7

7.9

1.63

3178

25165

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1208

7449

1.68

58.34

2.8

2.3

u/l

8721.2

5913.6

1.47

451

2977

(3026493) Urate [Moles/volume] in Serum or Plasma

3296

25236

1.41

57.60

2.6

2.5

umol/l

2714.5

3529.3

0.78

2866

22280

(3027945) Reticulocytes/100 erythrocytes in Blood

1477

9616

1.60

57.44

2.6

2.9

1.8

1.7

0.43

1304

8579

(3005719) IgG [Mass/volume] in Serum or Plasma

1307

8261

1.65

57.33

2.6

g/l

10.3

10.4

0.37

1192

7600

(3014599) Egg white IgE Ab [Units/volume] in Serum

266

921

2.93

56.73

1.2

1.1

u/ml

10.5

1.9

1.24

155

235

(3017143) Hepatitis C virus Ab [Presence] in Serum

2271

16298

1.47

56.26

1.8

1.6

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

476

2193

2.21

55.67

3.5

mmol/l

24.7

24.5

0.34

425

1929

(4010399)

1116

6848

1.69

54.77

1.5

1.4

—

(3042517) Benzodiazepines panel - Urine

102

182

5.64

54.39

3.6

2.4

—

(40767503) Oxygen content in Capillary blood by calculation

430

1924

2.28

53.97

3.0

2.4

16.7

16.6

0.06

217

961

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10214

93612

1.39

53.36

5.7

4.9

mmol/mol

39.1

38.7

3.95

9562

87803

(3020779) Urea [Moles/volume] in Serum or Plasma

1251

7967

1.63

53.04

8.0

8.1

mmol/l

8.6

8.8

0.53

1204

7633

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1519

10133

1.56

52.95

3.6

4.4

u/l

228.1

238.9

2.83

1430

9605

(3002385) Erythrocyte distribution width [Ratio]

10267

94227

1.39

52.80

21.0

14.6

13.6

13.5

6.05

10156

92297

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

9373

84808

1.35

52.55

4.0

3.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

176

497

3.58

52.54

2.8

2.1

umol/l

202.9

148.9

0.98

244

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10900

101128

1.43

52.15

4.5

3.9

mmol/l

5.9

5.8

9.72

10063

93715

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2249

16322

1.45

52.13

2.8

2.9

mmol/l

2.4

0.03

1953

14205

(3023183) Ammonium ion [Moles/volume] in Plasma

427

1950

2.23

51.02

2.4

3.0

umol/l

33.1

34.8

0.75

365

1685

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

709

3892

1.87

50.94

3.4

0.7

0.31

687

3735

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

850

4954

1.76

50.11

2.1

1.8

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

896

5322

1.73

49.39

10.5

9.6

0.6

0.7

2.35

890

5286

(3004119) Hemoglobin [Mass/volume] in Venous blood

873

5149

1.74

49.35

3.8

g/l

131.4

130.4

0.65

855

5032

(3021901) Oxygen saturation in Capillary blood

362

1566

2.35

49.16

3.2

3.0

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

20.61

48.69

1.0

u/ml

0.1

0.0

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

894

5329

1.73

48.64

10.4

9.5

1.4

0.43

888

5293

(3012501) Base excess in Blood by calculation

447

2124

2.14

48.36

4.2

4.0

mmol/l

2.2

2.3

0.31

284

1406

(3013290) Carbon dioxide [Partial pressure] in Blood

447

2125

2.14

48.30

4.2

4.0

kpa

5.0

0.36

436

2086

(1616796) Gas panel - Central venous blood

437

2067

2.15

47.84

4.0

3.5

—

(3027315) Oxygen [Partial pressure] in Blood

448

2141

2.13

47.76

4.2

4.0

kpa

8.9

8.8

0.34

437

2101

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

24.35

47.75

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

3249

25455

1.37

47.75

4.8

4.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1025

6370

1.66

47.69

1.9

1.8

g/l

1.4

1.3

1.01

945

5884

(3010421) pH of Blood

495

2465

2.05

47.29

4.3

4.0

7.4

0.50

436

2087

(40761511) CBC panel - Blood by Automated count

12174

115878

1.58

47.24

15.8

11.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1404

9454

1.54

46.58

4.0

3.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1075

6807

1.63

46.40

2.6

2.3

ug/l

5.2

7.5

5.10

935

5939

(3028271) Lactate [Moles/volume] in Capillary blood

339

1463

2.35

46.30

2.1

1.9

mmol/l

1.7

0.17

331

1431

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

797

4674

1.75

45.90

10.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

774

4516

1.76

45.37

10.8

9.9

mmol/l

24.2

0.09

738

4238

(3041096) Erythrocytes [Presence] in Urine by Automated

3713

29919

1.33

44.75

3.7

2.9

—

(3000494) Fungus identified in Specimen by Culture

1693

11950

1.48

44.68

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1324

8895

1.54

44.26

2.3

2.4

g/l

0.2

0.12

1222

8314

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1180

7727

1.58

44.19

2.5

2.3

au/ml

19.4

22.8

0.44

522

(3052851) Hemolysis interference index of Serum or Plasma

556

2957

1.92

43.98

2.8

3.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3685

29782

1.33

43.18

2.2

2.0

—

(3022145) Colonoscopy Study observation

1597

11238

1.48

42.66

1.3

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

471

2407

1.99

41.86

1.6

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1094

7128

1.58

41.78

1.3

au/ml

32.4

45.9

0.99

293

(3028626) Oxygen [Partial pressure] in Capillary blood

489

2535

1.96

41.71

5.5

4.8

kpa

8.5

8.8

2.37

455

2379

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1144

7537

1.57

41.62

4.0

3.7

mmol/l

1.2

3.33

997

6624

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

408

1984

2.09

41.57

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

408

1985

2.09

41.51

1.4

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4886

41220

1.29

41.28

4.2

3.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

752

4479

1.72

40.90

1.3

u/ml

2.3

1.0

0.88

385

(3023520) Reticulocytes [#/volume] in Blood

1068

6968

1.58

40.51

2.6

2.8

e9/l

71.4

70.4

0.40

764

5151

(3000570) Elastase.pancreatic [Mass/mass] in Stool

519

2785

1.90

39.94

1.5

1.4

ug/g

290.7

281.1

0.45

271

1550

(3011397) Hemoglobin [Presence] in Urine by Test strip

3055

24253

1.34

39.91

3.8

3.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2555

19743

1.36

39.88

1.7

1.6

pmol/l

19225821.1

29769146.5

0.59

2143

16776

(3017181) Myelocytes/100 leukocytes in Blood

1253

8508

1.52

39.67

4.3

0.8

0.9

0.50

354

2206

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1304

8940

1.51

39.43

1.3

1.2

iu/ml

131.6

147.3

0.52

452

3459

(40768804) Tissue Pathology biopsy report

5001

42490

1.28

39.41

2.1

2.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

1202

8114

1.53

39.09

4.4

4.3

0.1

0.46

326

2047

(3025941) Bacteria identified in Stool by Culture

1013

6621

1.57

38.05

1.3

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1065

7066

1.55

37.42

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1031

6791

1.56

37.41

2.5

g/l

66.6

66.7

0.22

958

6259

(3009466) Valproate [Moles/volume] in Serum or Plasma

332

1555

2.16

37.30

5.7

5.3

umol/l

356.7

371.2

0.95

287

1351

(3027273) Bicarbonate [Moles/volume] in Venous blood

665

3926

1.73

37.30

4.3

3.6

mmol/l

25.0

25.2

0.44

642

3796

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

441

2301

1.95

36.92

2.0

2.1

g/l

0.0

0.92

415

2117

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

623

3622

1.76

36.89

5.0

4.0

52.3

49.2

2.40

615

3579

(3002179) Metamyelocytes/100 leukocytes in Blood

1151

7797

1.52

36.73

4.0

4.1

0.5

0.6

0.81

259

1601

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

12.99

36.53

1.1

1.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

167

572

2.94

36.45

2.1

1.6

iu/ml

1094860.0

1918627.0

0.49

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

476

2564

1.89

36.20

2.0

2.3

g/l

0.7

0.8

0.26

431

2239

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

411

2114

1.97

35.87

2.0

2.2

g/l

0.0

0.33

386

1937

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

12.53

35.74

1.0

u/ml

0.4

0.06

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

406

2084

1.98

35.65

2.0

2.2

g/l

0.0

0.00

387

1933

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

221

887

2.52

35.48

2.0

2.2

—

(3024928) Oxygen saturation in Venous blood

380

1909

2.02

35.46

2.9

4.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

440

2331

1.92

35.21

2.0

2.1

g/l

38.4

38.1

0.42

401

2036

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

468

2533

1.88

35.07

1.3

—

(3025159) Blasts/100 leukocytes in Blood

1133

7724

1.51

35.02

4.4

0.0

0.2

1.92

272

1739

(3029937) Albumin [Presence] in Urine by Test strip

3433

28117

1.30

34.99

4.5

3.7

estimate

0.0

1.73

1428

9986

(3007461) Platelets [#/volume] in Blood

12813

124448

1.77

34.77

25.9

17.7

e9/l

260.7

257.2

8.11

12628

121556

(3014133) Dog dander IgE Ab [Units/volume] in Serum

419

2203

1.93

34.30

1.1

u/ml

7.0

4.9

1.07

221

911

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

533

3030

1.79

34.08

2.0

2.2

g/l

7.2

7.4

1.10

439

2287

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

510

2865

1.81

33.92

2.0

2.2

g/l

3.0

3.1

0.82

430

2241

(3004588) Protein electrophoresis panel - Serum or Plasma

841

5405

1.59

33.86

2.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

156

4.83

33.80

1.1

1.0

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

531

3026

1.79

33.67

2.0

2.2

—

(3035941) MCH [Entitic mass]

12815

124556

1.75

33.53

25.7

17.6

30.2

30.1

0.72

12733

123062

(3048929) Epstein Barr virus Ab [Presence] in Serum

762

4795

1.62

33.48

1.4

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

530

3026

1.78

33.39

2.0

2.2

g/l

3.9

3.8

0.41

423

2177

(3026361) Erythrocytes [#/volume] in Blood

12816

124581

1.75

33.35

25.9

17.6

e12/l

4.5

7.21

12599

121428

(3024731) MCV [Entitic volume]

12814

124562

1.75

33.26

25.8

17.6

90.4

90.3

4.04

12733

123068

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

500

2815

1.81

33.02

2.0

2.2

g/l

10.2

10.3

0.24

450

2381

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1442

10421

1.43

32.95

1.5

—

(3010813) Leukocytes [#/volume] in Blood

12817

124621

1.74

32.94

25.9

17.7

e9/l

7.0

6.7

44.68

12596

121423

(3000963) Hemoglobin [Mass/volume] in Blood

12817

124624

1.74

32.89

26.1

17.7

g/l

135.2

136.1

10.08

12734

123136

(3019225) pH of Specimen

1253

8851

1.46

32.33

4.1

4.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2984

24211

1.30

32.18

1.8

1.7

—

(36660697) Celiac disease serology panel - Serum

1369

9843

1.44

32.13

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

389

2044

1.93

31.92

1.1

u/ml

6.7

5.7

0.39

224

891

(3009445) Proteinase 3 Ab [Units/volume] in Serum

679

4210

1.65

31.63

1.4

1.6

u/ml

7.7

11.8

—

132

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

499

2851

1.78

31.37

1.4

1.3

u/ml

11.7

9.1

0.27

444

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

578

3467

1.70

30.56

2.0

1.9

—

(3019060) Gas panel - Arterial blood

821

5376

1.56

30.44

5.1

4.8

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

530

3110

1.73

30.36

1.4

1.3

u/ml

33.0

38.8

0.21

212

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

477

2718

1.78

30.26

1.8

1.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

488

2803

1.77

30.13

1.3

u/ml

4.5

6.0

0.33

281

(3003327) Ova and parasites identified in Stool by Light microscopy

679

4263

1.62

30.07

1.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

976

6653

1.50

30.05

3.0

2.9

ng/l

157.2

170.3

0.51

863

5961

(3007456) Orange IgE Ab [Units/volume] in Serum

10.34

29.76

1.0

u/ml

0.1

0.31

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

344

1779

1.96

29.60

1.1

u/ml

0.8

0.4

0.52

132

407

(3022313) Gas panel - Capillary blood

689

4359

1.61

29.57

4.8

4.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

871

5825

1.53

29.33

1.7

1.6

mu/l

344.4

312.3

1.39

779

5241

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

558

3357

1.69

29.18

1.5

1.6

titre

206.0

321.0

0.80

144

(3008152) Bicarbonate [Moles/volume] in Arterial blood

794

5210

1.56

29.15

7.7

6.8

mmol/l

24.3

24.5

0.56

751

4829

(40761536) Microorganisms panel - Urine sediment

1297

9398

1.42

29.01

4.5

3.6

—

(3007463) Buprenorphine [Presence] in Urine

6.89

28.77

10.5

4.8

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

133

460

2.91

28.63

1.1

1.0

u/ml

12.3

8.9

0.29

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

486

2832

1.74

28.54

1.3

1.5

mg/l

488.7

490.9

0.02

468

2695

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1683

12772

1.36

28.52

2.2

2.0

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

10.02

28.24

1.0

u/ml

0.3

0.1

0.58

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

189

789

2.42

27.97

1.8

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3159

26202

1.27

27.94

4.3

4.1

mg/mmol

11.5

10.6

0.31

2016

16930

(3030981) Hyaline casts [#/volume] in Urine by Automated count

740

4836

1.56

27.64

2.9

2.6

e6/l

0.2

0.3

0.14

715

4683

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

262

1261

2.10

27.54

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

501

2981

1.71

27.30

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

461

2681

1.75

27.27

1.3

1.5

iu/ml

20.1

11.4

0.49

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

522

3145

1.69

27.15

2.2

2.0

ug/l

1.6

2.3

0.95

459

2773

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

660

4235

1.59

26.69

1.6

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

520

3164

1.67

26.06

1.2

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

431

2498

1.75

25.82

1.2

1.4

mmol/l

3.7

0.32

408

2349

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1039

7389

1.44

25.66

3.1

3.4

pmol/l

4.5

0.36

924

6640

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

277

1408

1.99

25.11

1.2

1.3

nmol/l

0.5

1.7

0.76

263

1363

(3012516) Albumin [Mass/volume] in Urine

3001

25016

1.26

24.97

3.5

3.3

mg/l

313.8

453.1

1.04

1976

16047

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1358

10161

1.37

24.96

2.0

1.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

671

4393

1.56

24.85

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

277

1416

1.98

24.72

1.2

1.3

nmol/l

0.3

0.2

0.17

(3009542) Hematocrit [Volume Fraction] of Blood

11041

105315

1.28

24.55

18.5

12.8

40.0

40.2

1.54

8551

82517

(3019150) Specific gravity of Urine by Refractometry

2785

23063

1.26

24.44

4.3

3.6

kg/l

1.0

0.01

406

3407

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

604

3876

1.58

24.41

1.8

g/l

1.6

1.5

1.33

519

3319

(3044290) Cell count panel - Cerebral spinal fluid

406

2351

1.75

24.41

1.2

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

394

2271

1.76

24.08

1.3

u/ml

4.8

4.5

0.04

168

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

667

4412

1.54

23.58

2.0

u/l

40.0

39.5

0.28

615

3998

(3014765) Yersinia sp identified in Stool by Organism specific culture

512

3186

1.63

23.51

1.2

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

385

2221

1.76

23.47

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

606

3933

1.57

23.33

2.2

2.0

—

(3014051) Protein [Presence] in Urine by Test strip

394

2293

1.74

23.29

2.2

2.1

—

(3000330) Specific gravity of Urine by Test strip

678

4527

1.52

22.95

3.3

3.1

—

(3036489) Thrombin time

632

4156

1.55

22.95

2.3

2.5

20.7

21.3

2.92

561

3574

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

558

3567

1.59

22.93

1.4

1.3

—

(3042951) Complement C1q Ab [Units/volume] in Serum

7.10

22.85

1.1

1.0

u/ml

9.5

27.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

511

3201

1.62

22.85

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

940

6720

1.43

22.49

4.4

4.0

ng/l

88.8

86.3

0.32

819

5910

(3016650) Hepatitis A virus Ab [Presence] in Serum

348

1975

1.78

22.46

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

418

2510

1.69

22.06

1.3

1.6

e6/l

2465.1

2368.8

0.02

336

2033

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

380

2226

1.73

21.96

1.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

358

2066

1.75

21.82

2.7

2.1

g/l

130.9

0.00

279

1513

(3017732) Neutrophils [#/volume] in Blood

1036

7583

1.40

21.65

2.6

e9/l

4.3

4.1

1.16

802

6149

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

404

2417

1.69

21.62

1.3

u/ml

51.6

42.7

0.48

231

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

416

2509

1.68

21.60

1.2

1.6

e6/l

16.7

22.7

0.55

314

1931

(3018001) Oat IgE Ab [Units/volume] in Serum

4.96

21.52

1.1

1.0

u/ml

2.8

0.1

0.52

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

11114

106454

1.27

21.52

4.6

4.2

mmol/l

2.8

4.90

10346

99543

(3022621) pH of Urine by Test strip

915

6563

1.42

21.48

2.9

2.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

246

1274

1.95

21.20

1.4

1.5

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

7.51

21.19

1.0

1.1

u/ml

0.0

0.1

0.68

(3018405) Lactate [Moles/volume] in Arterial blood

466

2909

1.62

21.15

4.9

3.9

mmol/l

1.5

1.4

1.16

459

2855

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

339

1946

1.76

21.06

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

513

3284

1.58

20.97

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

530

3420

1.57

20.93

5.2

5.1

1.9

1.7

2.64

501

3183

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

181

3.66

20.83

1.3

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

706

4851

1.48

20.80

1.1

u/ml

37.4

2.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

496

3164

1.59

20.59

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

550

3593

1.55

20.58

2.1

1.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

444

2765

1.63

20.36

1.4

1.3

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

6.90

20.33

1.0

u/ml

0.0

0.1

0.49

(3023420) DNA double strand Ab [Units/volume] in Serum

240

1251

1.94

20.32

1.8

1.6

iu/ml

37.4

27.4

0.44

(3045414) Leukocytes [Presence] in Urine

679

4654

1.48

20.26

1.9

1.8

—

(3047181) Lactate [Moles/volume] in Blood

455

2855

1.61

20.23

5.5

5.7

mmol/l

1.4

1.3

2.71

414

2502

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

374

2233

1.69

20.19

3.4

3.7

57.4

56.9

0.27

374

2233

(3035947) Staphylolysin Ab [Units/volume] in Serum

118

462

2.57

20.16

1.2

1.1

iu/ml

3.0

3.9

1.00

(3024980) IgG subclass 4 [Mass/volume] in Serum

322

1847

1.76

20.08

1.6

g/l

0.7

0.20

245

1408

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

284

1570

1.83

20.04

1.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

520

3379

1.56

19.93

5.3

5.2

0.9

0.92

491

3151

(3025468) Yersinia sp identified in Specimen by Organism specific culture

237

1239

1.93

19.90

1.4

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

589

3937

1.52

19.85

5.2

4.4

mmol/l

24.8

24.6

1.24

558

3684

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

237

1242

1.92

19.76

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

237

1244

1.92

19.67

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

237

1247

1.92

19.53

1.4

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

237

1248

1.92

19.48

1.4

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10555

100796

1.23

19.35

3.8

3.5

mmol/l

1.4

1.3

30.76

9803

94139

(40768443) Skin Pathology biopsy report

635

4334

1.49

19.35

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

419

2614

1.62

19.09

1.4

1.3

u/ml

267.3

258.2

0.27

262

1644

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

175

833

2.12

19.08

11.9

11.7

mmol/l

0.6

1.06

164

764

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

312

2.87

18.86

1.1

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

14.18

18.47

1.1

1.0

u/ml

0.4

0.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

419

2660

1.59

17.79

2.3

2.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10952

105207

1.23

17.75

4.2

3.9

mmol/l

4.7

9.33

10271

99029

(3007566) Smooth muscle Ab [Titer] in Serum

476

3118

1.55

17.63

1.2

1.3

titre

107.7

116.3

0.12

299

(3043409) Potassium [Moles/volume] in Arterial blood

395

2485

1.61

17.43

4.9

4.1

mmol/l

3.8

3.9

0.43

358

2338

(3020717) Zinc [Moles/volume] in Serum or Plasma

139

628

2.23

17.33

1.6

umol/l

23.0

24.5

0.24

130

599

(3008898) HLA-B27 [Presence]

672

4743

1.44

17.22

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

354

2177

1.64

17.13

1.8

1.7

—

(3002256) Pathology report gross observation

1626

13120

1.27

17.12

1.3

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

504

3367

1.52

17.06

2.8

3.2

g/l

3.5

0.01

473

3191

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

431

2782

1.57

17.05

1.9

2.0

mg/l

10.7

0.02

410

2612

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10876

104501

1.22

17.03

4.2

3.8

mmol/l

1.4

1.5

33.36

10151

98014

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

291

1702

1.73

17.01

1.7

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

914

6825

1.36

16.83

1.1

—

(44813793)

178

896

2.00

16.75

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

255

1443

1.78

16.73

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3009

25995

1.20

16.64

1.7

1.6

mmol/l

1.5

1.4

7.54

2550

22334

(3021788) Differential panel - Synovial fluid

282

1650

1.72

16.47

1.6

1.5

—

(3003181) Sodium [Moles/volume] in Urine

253

1440

1.77

16.29

1.7

1.5

mmol/l

61.0

64.6

0.63

196

1150

(3016018) Differential panel - Cerebral spinal fluid

232

1288

1.82

16.24

1.2

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

412

2665

1.56

16.17

3.5

4.2

u/ml

0.3

0.11

224

1494

(3008037) Lactate [Moles/volume] in Venous blood

287

1697

1.71

16.15

3.7

3.0

mmol/l

1.5

1.6

0.61

280

1656

(3027135) IgG subclass 1 [Mass/volume] in Serum

216

1180

1.84

15.94

1.5

1.3

g/l

6.6

0.06

153

821

(4062490)

216

1180

1.84

15.94

1.6

1.3

—

(3020891) Body temperature

499

3378

1.50

15.87

6.3

4.7

—

(3034770) Mitochondria Ab [Titer] in Serum

459

3055

1.52

15.83

1.2

1.3

titre

875.0

979.6

0.07

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

495

3351

1.50

15.74

2.8

174.8

179.0

0.48

470

3180

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

260

2.86

15.69

3.5

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

260

2.86

15.69

3.5

2.7

—

(3019977) pH of Arterial blood

108

458

2.37

15.66

3.5

2.7

7.4

1.21

146

(3028192) IgG subclass 2 [Mass/volume] in Serum

215

1180

1.84

15.64

1.5

1.3

g/l

2.8

2.9

0.47

152

824

(3024139) IgG subclass 3 [Mass/volume] in Serum

215

1180

1.84

15.64

1.5

1.3

g/l

0.3

0.4

1.60

151

821

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

139

658

2.12

15.47

1.6

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

170

867

1.97

15.46

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

170

868

1.97

15.41

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

170

870

1.97

15.31

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

195

1045

1.88

15.30

1.7

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

225

1262

1.80

15.25

1.7

1.6

—

(3011985) Renin [Units/volume] in Plasma

240

1379

1.75

14.99

1.5

1.6

mu/l

85.1

66.2

0.31

218

1239

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

170

877

1.95

14.97

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

170

877

1.95

14.97

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

170

879

1.95

14.87

1.2

—

(3007700) Barley IgE Ab [Units/volume] in Serum

4.93

14.48

1.1

1.0

u/ml

36.8

0.7

0.49

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

132

629

2.11

14.48

2.7

3.0

nmol/l

89.5

103.3

0.36

125

622

(3007542) Rye IgE Ab [Units/volume] in Serum

4.66

14.43

1.1

1.0

u/ml

47.3

0.2

0.50

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

7.70

14.41

1.1

1.3

mmol/l

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

169

883

1.93

14.36

1.2

1.3

mmol/l

1.8

1.9

2.80

156

826

(3047007) Chlamydophila sp Ab [Presence] in Serum

298

1840

1.63

14.26

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

224

1281

1.76

14.25

1.4

pmol/l

300.4

359.4

1.11

177

1002

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

361

2343

1.56

14.01

2.9

3.2

mg/l

34.8

48.5

1.30

284

1887

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

165

866

1.92

13.85

15.5

13.4

nmol/l

771.7

825.7

0.81

159

835

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

352

2283

1.56

13.72

2.7

3.2

ratio

1.3

2.4

1.20

204

(3034274) Bile acid [Moles/volume] in Serum --fasting

362

2364

1.55

13.68

2.1

2.3

umol/l

8.2

6.5

0.59

264

1729

(3004809) Band form neutrophils/100 leukocytes in Blood

245

1455

1.70

13.64

3.2

3.3

1.0

1.4

1.86

173

1142

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

522

3674

1.44

13.63

1.7

1.6

iu/ml

2.1

7.1

0.51

100

764

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

169

899

1.89

13.62

20.7

19.4

nmol/l

5670.9

2460.9

0.33

162

868

(3034860) Kappa light chains.free [Mass/volume] in Serum

359

2343

1.55

13.61

2.9

3.2

mg/l

52.1

76.2

0.48

281

1884

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

357

2329

1.55

13.56

1.4

—

(3036180) Methadone [Presence] in Urine

7.61

13.55

2.4

2.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

888

6820

1.32

13.54

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

109

496

2.21

13.47

1.3

nmol/l

144.7

134.8

1.11

109

496

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

199

1120

1.79

13.40

2.1

2.5

nmol/l

23.8

20.1

3.04

185

1072

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

187

1035

1.82

13.31

1.3

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

349

2277

1.55

13.26

1.6

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

238

1417

1.69

13.15

1.3

u/ml

31.6

53.7

0.51

101

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

168

903

1.87

13.14

1.1

1.2

titre

189.2

214.3

0.13

168

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

635

4659

1.38

13.07

2.4

2.3

—

(3004616) Nuclear Ab [Presence] in Serum

218

1271

1.73

13.00

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

316

2026

1.57

12.98

1.4

1.3

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

149

774

1.94

12.93

1.3

1.2

u/ml

67.1

67.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

115

546

2.12

12.79

1.4

1.3

u/l

315.3

297.0

0.09

105

499

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

272

1689

1.62

12.78

1.5

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

290

1830

1.60

12.75

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

807

6170

1.33

12.70

1.1

titre

150.8

227.4

0.56

173

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

149

779

1.92

12.69

1.3

1.2

u/ml

51.7

39.3

—

(3023419) Bacteria identified in Sputum by Culture

180

1000

1.81

12.68

2.1

2.9

—

(3049717) Cytology report of Urine Cyto stain

401

2728

1.48

12.52

2.5

2.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

162

875

1.86

12.50

2.9

3.3

61.6

56.4

2.10

565

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

448

2.22

12.44

1.0

—

(3023410) Appearance of Cerebral spinal fluid

206

1199

1.73

12.39

1.3

1.9

—

(3038026) Centromere Ab [Units/volume] in Serum

150

793

1.90

12.37

1.3

1.2

u/ml

49.8

45.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

158

851

1.87

12.31

1.6

1.4

nmol/l

1.7

1.5

1.24

141

761

(3038515) Glucose [Moles/volume] in Venous blood

255

1581

1.62

12.08

3.9

3.0

mmol/l

7.2

7.5

0.57

249

1546

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

207

2.81

12.05

1.3

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

142

744

1.92

12.05

1.3

1.2

u/ml

17.3

11.8

0.20

(3011648) Oxygen content in Venous blood

149

794

1.89

12.01

2.1

4.2

10.9

11.2

0.24

149

794

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

507

3639

1.41

11.91

2.6

3.0

92.9

93.2

0.11

481

3392

(3012920) Ethanol [Mass/volume] in Serum or Plasma

7.40

11.83

1.0

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

124

626

1.99

11.73

1.3

1.5

u/l

5.6

6.0

0.32

104

535

(3006442) Creatine [Moles/volume] in Serum or Plasma

137

716

1.92

11.72

1.5

1.4

umol/l

61.9

68.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

325

2149

1.53

11.67

1.6

e6/l

14020.8

13244.9

0.09

218

1556

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

117

580

2.03

11.65

1.1

u/ml

9.7

10.9

0.12

114

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

292

1898

1.55

11.35

1.3

1.2

u/ml

3.4

3.7

0.11

105

643

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

197

1162

1.71

11.33

6.0

7.0

mg/l

10.8

11.1

0.27

183

1078

(3013005) Retinol [Moles/volume] in Serum or Plasma

115

576

2.01

11.15

2.1

2.2

umol/l

2.1

1.9

1.88

109

542

(21491868) Cryoglobulin [Mass/volume] in Serum

360

2.29

11.12

1.2

g/l

0.2

—

(3044941) Cell count panel - Synovial fluid

224

1378

1.64

10.99

1.5

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

142

769

1.86

10.93

3.9

4.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

143

777

1.85

10.90

2.9

2.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

143

779

1.84

10.81

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

207

1258

1.66

10.67

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

176

1024

1.73

10.67

2.8

3.2

nmol/l

5.0

9.9

0.43

168

993

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

378

2632

1.45

10.54

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

143

786

1.83

10.52

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1828

15675

1.19

10.45

1.6

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

920

7347

1.27

10.43

1.4

iu/l

22.7

24.9

1.34

769

6282

(1002224) Polysomnography panel

657

5021

1.32

10.41

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

158

902

1.76

10.26

2.8

2.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

290

1928

1.52

10.21

1.8

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

248

1596

1.56

10.13

1.6

1.5

—

(3045716) Anion gap in Serum or Plasma

388

2.17

10.12

2.6

2.4

mmol/l

9.6

9.3

0.22

296

(21494755) Public health laboratory ask at order entry panel

1200

14422

0.82

10.00

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

150

850

1.77

10.00

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

232

1478

1.58

9.91

1.1

g/l

1.5

0.61

219

1341

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1358

11388

1.21

9.84

4.2

3.9

31.2

32.1

2.26

1020

8054

(3019832) Treponema pallidum Ab [Presence] in Serum

2084

18165

1.17

9.78

1.8

1.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

328

2261

1.46

9.68

5.8

5.9

iu/ml

837.7

1485.7

0.32

294

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

254

1662

1.54

9.65

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

137

765

1.80

9.62

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

137

765

1.80

9.62

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

137

765

1.80

9.62

1.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

277

1849

1.51

9.60

1.3

1.2

u/ml

3.1

3.9

0.92

124

814

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

295

1995

1.49

9.59

2.4

2.3

nmol/l

0.9

0.8

0.66

239

1688

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

100

507

1.98

9.44

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

298

2027

1.48

9.43

1.2

1.1

au/ml

10.6

11.2

0.07

136

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

370

2624

1.42

9.39

1.5

1.4

u/ml

8.7

23.2

—

(40761535) Cells panel - Urine sediment

938

7610

1.25

9.30

3.9

3.4

—

(3003694) ABO and Rh group [Type] in Blood

3746

34176

1.13

9.20

1.6

—

(3017509) Phencyclidine [Presence] in Urine

197

2.59

9.19

2.8

1.8

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

192

2.61

9.12

1.1

umol/24h

0.6

0.7

0.44

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

447

2.02

9.02

1.6

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

280

1899

1.48

9.01

1.5

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

405

2940

1.39

9.00

1.8

1.9

iu/l

3.1

6.9

0.82

142

1163

(3040151) Glucose [Moles/volume] in Capillary blood

172

1044

1.66

8.99

14.8

11.4

mmol/l

7.9

7.2

0.38

147

861

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

167

1010

1.66

8.86

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

183

1134

1.62

8.82

1.5

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

954

7801

1.24

8.82

2.3

2.1

nmol/l

11.6

12.2

1.51

836

6955

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

211

1353

1.57

8.82

1.5

1.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

156

2.76

8.77

3.4

2.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

453

1.99

8.71

1.6

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

281

1923

1.47

8.66

1.9

2.0

titre

2.7

7.8

—

(3037756) Immunofixation for Serum or Plasma

231

1520

1.53

8.61

1.8

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

143

841

1.71

8.44

1.3

1.2

—

(4024509)

148

880

1.69

8.40

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

379

2.06

8.33

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

270

1848

1.47

8.33

3.4

3.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

381

2.05

8.22

3.1

2.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

193

1237

1.57

8.12

1.5

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

460

1.94

8.02

1.8

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

460

1.94

8.02

1.8

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

460

1.94

8.02

1.8

2.0

—

(3016330) Potassium [Moles/time] in 24 hour Urine

158

2.66

8.02

1.1

1.3

—

96.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

141

839

1.69

8.00

1.3

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

461

1.94

7.98

1.8

2.0

—

(3003338) MCHC [Mass/volume]

10142

98383

1.13

7.95

21.9

15.1

g/l

332.7

333.1

3.46

10095

97633

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

254

1735

1.47

7.94

3.6

3.3

u/ml

301.7

1684.5

1.58

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

339

2443

1.40

7.92

1.5

u/ml

114.4

110.7

0.15

501

(3039000) Anion gap in Blood

279

1942

1.45

7.91

6.8

6.9

mmol/l

11.7

11.2

1.11

256

1728

(3018572) Chloride [Moles/volume] in Blood

279

1943

1.45

7.89

6.8

6.9

mmol/l

104.4

105.4

2.15

256

1729

(21494815) CD4 cells/100 lymphocytes in Specimen

164

1019

1.62

7.88

2.0

2.6

40.9

42.8

—

141

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

200

1305

1.54

7.79

1.1

94.0

95.4

0.31

187

1229

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

148

903

1.65

7.66

1.0

1.1

mg/l

284.1

286.9

0.18

136

815

(43055442) Apixaban [Mass/volume] in Serum or Plasma

3.26

7.63

1.4

1.5

ug/l

122.1

122.2

0.00

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

126

740

1.71

7.53

2.4

2.7

97.1

97.9

0.10

121

686

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

110

622

1.77

7.51

1.8

127.7

132.5

0.30

105

581

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

257

1788

1.45

7.34

1.1

120.4

116.2

1.32

232

1621

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

142

870

1.64

7.25

2.0

2.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

227

1546

1.48

7.25

1.3

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

463

1.88

7.23

2.1

2.8

ug/l

1.1

1.3

0.57

434

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

106

601

1.77

7.19

1.1

nmol/l

1.4

7.6

1.30

119

(3008295) Osmolality of Serum or Plasma

156

981

1.60

7.17

1.6

1.5

mosm/kgh2o

278.7

281.6

0.76

115

760

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

198

2.38

7.15

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

261

2.19

7.15

1.4

1.3

nmol/l

106.1

114.5

0.19

196

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

264

1856

1.43

7.14

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

157

994

1.59

7.03

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

149

932

1.61

7.02

2.9

3.4

mu/l

25.8

27.7

0.24

141

879

(3037121) Protein [Mass/volume] in Urine

443

3395

1.32

7.00

3.3

g/l

0.3

0.4

1.45

203

1546

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.49

6.97

2.2

1.4

umol/l

45.2

41.1

0.24

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1010

8510

1.20

6.96

3.7

4.0

ug/l

19.3

26.1

0.28

791

6638

(3011412) CD3 cells [#/volume] in Blood

177

1155

1.54

6.95

2.2

2.7

e9/l

1.3

1.2

1.13

114

678

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

601

1.75

6.91

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

373

1.96

6.87

3.6

4.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

649

5233

1.25

6.86

1.3

miu/ml

216.4

228.4

0.36

280

2510

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

481

1.84

6.76

2.0

2.3

nmol/l

145.0

156.0

0.42

413

(1761482) Bacteria [#/volume] in Urine by Culture

286

2069

1.39

6.61

4.2

3.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

167

1089

1.54

6.60

2.3

2.0

mg/l

22.0

25.5

0.39

287

(3028679) Herpes simplex virus Ab [Presence] in Serum

122

739

1.66

6.56

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.34

6.53

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

239

1682

1.43

6.47

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

126

773

1.64

6.46

2.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

403

1.89

6.44

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

460

1.83

6.44

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

156

1009

1.55

6.41

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

107

630

1.70

6.41

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

161

1049

1.54

6.40

1.1

mg/l

222.4

244.7

1.01

140

929

(3045142) Bone marrow Pathology biopsy report

147

942

1.57

6.30

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

164

1078

1.53

6.27

1.2

mg/l

33.2

40.4

2.13

132

901

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

3.83

6.25

1.2

1.1

u/l

424.1

77.3

0.41

(1175426) CD3 cells/100 lymphocytes in Blood

147

944

1.56

6.25

1.9

2.4

73.8

73.2

0.23

142

910

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

103

605

1.71

6.24

1.4

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

164

1080

1.52

6.23

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

555

4448

1.26

6.21

1.5

1.4

u/l

9.7

9.3

0.29

454

3627

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

562

1.73

6.17

1.4

72.5

72.3

0.04

540

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

165

1092

1.52

6.13

1.6

56.5

54.7

0.21

692

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

199

1369

1.46

6.11

1.2

1.1

iu/ml

1.7

2.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

368

1.91

6.11

2.9

2.4

—

(3012441) Differential panel - Pleural fluid

115

700

1.65

6.10

1.6

1.5

—

(3036603) Volume of Urine

102

602

1.70

6.08

1.5

1.6

1984.1

1995.9

0.02

116

(40760888) Immunoglobulin light chains.free panel - Serum

248

1780

1.40

6.04

3.0

3.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

916

7764

1.19

5.94

2.9

2.4

ml/min/173m2

67.9

71.4

1.52

340

2973

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

316

1.97

5.93

2.2

2.0

—

(4027681)

133

847

1.58

5.89

1.4

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

310

2319

1.34

5.86

1.2

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

304

1.98

5.85

1.4

1.3

umol/l

16.6

16.9

0.21

270

(3051611) Lipemic interference index of Serum or Plasma

148

968

1.53

5.83

3.6

3.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

132

842

1.57

5.81

1.2

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

565

1.70

5.80

1.5

u/ml

34.5

19.8

0.49

112

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

551

1.71

5.77

1.4

mu/l

599.8

486.4

0.48

529

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

106

643

1.65

5.73

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

134

862

1.56

5.69

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

129

824

1.57

5.65

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

142

928

1.54

5.63

1.9

2.4

11.3

13.1

1.28

501

(3002523) Influenza virus A Ag [Presence] in Specimen

308

2318

1.34

5.61

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

134

869

1.55

5.51

1.2

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

210

2.15

5.47

1.4

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

450

3575

1.27

5.47

1.1

u/ml

5.7

5.6

0.02

510

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

126

808

1.56

5.45

1.1

iu/ml

8.2

8.4

0.03

202

(4306422)

256

1882

1.37

5.44

1.2

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

3.95

5.43

1.1

g/l

0.2

—

(3010503) CD19 cells [#/volume] in Blood

105

645

1.63

5.43

2.5

2.7

e9/l

0.2

0.3

0.21

100

627

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

225

2.09

5.37

1.4

1.6

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

125

2.48

5.26

2.3

3.5

umol/l

45.4

41.3

0.33

105

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

140

927

1.52

5.25

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

432

1.76

5.23

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

249

1837

1.36

5.20

1.1

iu/ml

72.5

5774.5

0.64

470

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

264

1.97

5.09

1.2

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

378

2968

1.28

5.09

3.3

3.6

u/ml

1283.4

2206.5

0.35

330

2542

(3008757) Leukocyte morphology finding [Identifier] in Blood

149

1012

1.48

4.97

3.7

3.8

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

484

1.70

4.97

1.4

1.3

titre

28.3

58.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

160

2.25

4.96

1.3

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

352

1.82

4.94

1.3

1.2

—

(3016038) Potassium [Moles/volume] in Urine

577

1.63

4.91

1.9

1.4

mmol/l

34.3

34.6

0.04

511

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

240

2.00

4.91

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.12

4.90

1.3

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

170

1188

1.44

4.90

1.3

1.4

mmol/l

10.8

11.4

0.32

230

(40761539) Cells [Type] in Urine sediment by Light microscopy

248

1.98

4.85

1.1

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

156

1075

1.46

4.85

1.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1084

12347

0.87

4.76

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

151

1038

1.46

4.76

1.3

1.4

titre

—

(21494814) CD8 cells/100 lymphocytes in Specimen

416

1.73

4.73

2.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

424

1.73

4.71

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

144

983

1.47

4.71

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

336

1.82

4.70

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

114

2.46

4.69

7.9

10.5

mmol/l

5.4

5.7

0.32

114

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

224

2.01

4.68

1.1

—

(4268621)

182

1301

1.40

4.65

2.5

2.3

—

(3017569) Oxygen content in Arterial blood

353

1.79

4.60

2.7

2.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

442

1.70

4.60

1.1

94.8

93.1

0.21

195

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

140

957

1.47

4.56

1.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

122

811

1.51

4.56

1.5

e6/l

2653.8

2410.5

0.10

594

(3028308) Erythrocytes [#/volume] in Pleural fluid

111

723

1.54

4.55

1.6

1.4

e6/l

19307.2

57684.7

2.14

427

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.61

4.55

1.1

1.2

umol/24h

1.8

1.7

0.12

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

430

1.70

4.50

1.1

1.2

92.7

92.5

0.01

194

(3027923) C peptide [Moles/volume] in Serum or Plasma

506

1.64

4.49

1.5

1.8

nmol/l

1.1

1.3

0.41

398

(3034988) Calcium [Moles/volume] in Capillary blood

203

2.02

4.35

1.5

3.3

mmol/l

1.2

2.75

193

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.23

4.35

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

167

1193

1.40

4.31

1.1

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

361

1.75

4.30

1.2

1.3

33.8

18.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1517

13674

1.12

4.27

1.9

1.8

—

(3003434) Protein [Mass/volume] in Pleural fluid

131

898

1.46

4.24

1.5

g/l

33.2

33.3

0.03

118

819

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

136

940

1.45

4.22

1.7

1.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

469

1.65

4.21

1.2

—

(3045424) Erythrocytes [Presence] in Urine

231

1749

1.33

4.15

1.6

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

124

846

1.47

4.12

2.2

3.0

e6/l

769.6

767.7

0.01

337

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

293

2295

1.28

4.10

1.4

u/l

19.6

23.5

1.48

247

1903

(3030313) Adrenal Ab [Titer] in Serum

135

2.22

4.07

1.2

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

360

1.73

4.06

1.0

1.2

—

(40768441) Liver Pathology biopsy report

113

760

1.49

4.04

1.4

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

122

835

1.47

4.00

1.6

31.9

32.6

0.06

506

(3012565) Volume of 24 hour Urine

499

1.61

4.00

2.2

2.1

2151.5

2018.0

0.42

457

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

251

1934

1.30

4.00

1.1

u/ml

4.1

3.1

0.47

994

(3038177) Helicobacter pylori Ab [Presence] in Serum

263

2043

1.29

3.95

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

232

1.90

3.94

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

232

1.90

3.94

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

232

1.90

3.94

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

232

1.90

3.94

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

103

686

1.51

3.88

1.6

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

389

1.67

3.84

1.4

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

437

1.63

3.77

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

437

1.63

3.77

1.2

1.4

—

(4094501)

308

2456

1.26

3.76

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

484

1.59

3.76

1.4

1.2

—

(3042631) Mycobacterium sp identified in Specimen

148

1064

1.40

3.74

2.6

2.7

—

(44806118)

157

1143

1.38

3.69

1.7

1.6

—

(44790047)

157

1143

1.38

3.69

1.7

1.6

—

(44790049)

157

1143

1.38

3.69

1.7

1.6

—

(44790048)

157

1143

1.38

3.69

1.7

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

735

8441

0.86

3.67

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

368

3003

1.23

3.67

5.0

5.3

mg/l

1.5

1.4

1.61

337

2822

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.11

3.64

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

312

1.73

3.64

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2361

21951

1.09

3.62

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

110

2.28

3.60

1.6

1.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

359

1.67

3.57

3.1

2.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

117

2.22

3.56

1.4

1.7

mg/l

0.9

2.2

1.52

(3025018) Bordetella pertussis Ab [Titer] in Serum

109

750

1.46

3.53

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

533

1.54

3.49

1.4

1.7

nmol/l

4.4

3.9

0.08

437

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

455

1.59

3.47

2.1

2.2

mg/l

9.1

9.5

0.30

372

(3020491) Glucose [Moles/volume] in Blood

116

812

1.43

3.44

1.6

1.9

mmol/l

6.5

6.2

0.45

615

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

273

1.76

3.43

1.6

ug/l

10.2

8.7

0.94

273

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

113

2.21

3.40

1.4

1.7

mg/l

0.5

2.5

3.70

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

113

2.21

3.40

1.4

1.7

mg/l

1.2

1.9

0.87

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

113

2.21

3.40

1.4

1.7

mg/l

1.6

1.8

0.12

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

113

2.21

3.40

1.4

1.7

mg/l

1.0

2.4

1.89

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

113

2.21

3.40

1.4

1.7

mg/l

0.3

1.1

2.63

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

113

2.21

3.40

1.4

1.7

mg/l

1.8

3.1

0.73

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

113

2.21

3.40

1.4

1.7

mg/l

3.7

1.9

0.45

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

113

2.21

3.40

1.4

1.7

mg/l

3.4

4.1

0.26

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

113

2.21

3.40

1.4

1.7

mg/l

0.5

1.3

1.03

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

357

1.66

3.39

2.1

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

357

1.66

3.39

2.1

2.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

107

2.25

3.37

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

159

1179

1.35

3.37

3.1

nmol/l

0.9

0.8

0.70

122

878

(40759632) Porphyrins [Mass/mass] in Stool

7.00

3.36

1.0

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

283

1.73

3.33

1.2

1.1

79.2

69.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

573

1.50

3.29

1.3

1.4

—

(3045788) Cell count panel - Pleural fluid

640

1.47

3.25

1.7

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

122

2.13

3.24

1.1

—

(40768806) Pleura Pathology biopsy report

103

715

1.44

3.22

1.5

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

296

2397

1.24

3.22

1.2

1.3

—

(3014891) Appearance of Pleural fluid

2.38

3.22

1.5

—

(4035726)

921

8202

1.13

3.22

1.4

—

(3051651) Icteric interference index of Serum or Plasma

617

1.48

3.21

4.0

3.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

561

1.50

3.19

1.3

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

114

808

1.41

3.19

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

434

1.57

3.17

1.6

1.5

6.1

4.0

—

105

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

364

1.62

3.16

2.1

2.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

420

3529

1.20

3.16

1.9

1.7

nmol/l

36.4

40.5

3.17

411

3451

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

110

776

1.42

3.16

1.2

ratio

1.1

0.66

266

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

115

818

1.41

3.16

1.3

1.4

umol/l

11.2

11.6

0.37

106

782

(3044927) Protein electrophoresis panel - Urine

106

743

1.43

3.16

1.3

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

213

1664

1.28

3.14

2.9

3.5

u/ml

329.1

583.2

0.62

191

1530

(3000012) Reticulocyte production index

443

1.56

3.14

1.8

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

124

2.10

3.13

1.3

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

282

1.70

3.10

1.4

1.1

101.6

81.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

138

2.03

3.10

1.0

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

259

2081

1.25

3.04

2.4

ug/min

142.0

112.5

0.40

149

1305

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

431

1.56

3.04

2.4

2.0

ug/min

41.4

156.0

1.19

100

(3024869) Neuronal Ab [Presence] in Serum

153

1.96

3.03

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

122

884

1.38

3.02

2.2

2.9

e6/l

530.7

516.7

0.13

726

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

293

1.67

2.98

1.2

105.9

104.9

0.10

278

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

522

1.50

2.96

1.7

1.6

u/field

1.7

2.9

1.32

378

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

234

1.75

2.94

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

264

1.71

2.94

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

264

1.71

2.94

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

264

1.71

2.94

1.2

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

467

1.52

2.93

1.3

u/l

14.8

12.2

0.66

434

(40768446) Kidney Pathology biopsy report

444

1.53

2.90

1.8

1.7

—

(4015189)

199

1.81

2.88

2.1

2.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

358

1.59

2.88

2.2

2.9

umol/l

28.4

28.8

0.09

262

(3028717) Thiamine [Mass/volume] in Blood

115

2.09

2.87

1.1

1.2

—

(3042733) HLA Ab [Presence] in Serum

390

1.57

2.86

4.3

4.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2469

23223

1.08

2.82

4.3

4.4

ug/l

2.4

2.9

0.56

2190

21014

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

107

769

1.39

2.81

1.5

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

173

1338

1.30

2.80

1.5

1.7

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

103

2.14

2.79

1.0

1.2

mg/l

55.5

43.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

670

1.42

2.78

1.3

1.4

mmol/l

6.9

6.2

1.45

625

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

285

2340

1.22

2.78

2.1

1.9

pmol/l

193.4

192.5

0.04

271

2229

(3035153) Lemon IgE Ab [Units/volume] in Serum

8.34

2.75

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

232

1.73

2.74

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

5.00

2.72

1.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

590

1.44

2.72

1.2

1.3

58.0

68.7

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.36

2.72

1.5

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

405

1.53

2.67

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

585

6659

0.87

2.66

1.5

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

430

1.51

2.65

1.8

2.8

e6/l

226.5

280.6

0.42

237

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.13

2.64

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.79

2.64

1.3

1.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.12

2.64

2.8

3.6

mg/l

1.2

1.3

0.07

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.25

2.60

1.2

1.1

u/l

21.1

24.0

0.21

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

182

1433

1.27

2.60

3.0

u/ml

458.2

1135.2

0.43

172

1327

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

275

1.64

2.57

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

234

1900

1.24

2.56

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.35

2.55

1.3

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

615

1.42

2.55

1.9

1.7

—

(3016750) Collection duration of Urine

500

1.46

2.53

2.1

2.2

min

519.5

500.1

0.77

393

(3010838) Calcium [Moles/time] in 24 hour Urine

476

1.47

2.52

1.5

1.7

mmol/24h

6.2

6.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

201

1.74

2.51

1.9

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

108

2.04

2.51

1.5

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

179

1.79

2.50

1.8

1.9

—

(4034850)

379

3231

1.18

2.50

9.2

8.6

—

(1761868) Lipid panel - Serum or Plasma

3987

41518

0.94

2.47

2.6

2.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

421

1.50

2.47

1.1

—

(3004775) Volume in Urine collected for unspecified duration

662

1.39

2.45

2.2

2.3

755.5

639.8

0.86

475

(3024263) Appearance of Synovial fluid

504

1.45

2.44

1.5

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

318

3764

0.84

2.43

1.4

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

138

1.89

2.40

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

623

1.40

2.39

1.1

1.2

u/ml

15.6

18.1

0.06

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

120

905

1.33

2.39

1.3

umol/l

4.7

5.6

2.24

108

843

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

425

1.48

2.37

1.2

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

243

2000

1.22

2.37

1.2

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

175

1.77

2.37

1.9

1.6

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

2.21

2.37

1.1

2.5

pmol/l

1.6

70.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.42

2.36

1.0

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

115

864

1.33

2.35

2.2

2.9

e9/l

0.2

0.20

724

(3009677) Dengue virus Ab [Presence] in Serum

2.50

2.35

1.1

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

267

1.61

2.33

1.1

—

330.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

418

4814

0.86

2.29

1.6

1.5

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.48

2.26

3.0

1.4

mu/l

4.8

2.6

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.55

2.26

1.0

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

3.89

2.25

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

120

916

1.31

2.22

1.3

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.09

2.22

1.9

2.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.33

2.21

1.0

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

100

744

1.35

2.20

2.3

1.9

g/24h

1.8

1.3

—

(3024316) Viscosity of Plasma

2.50

2.18

3.1

1.4

mpas

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

180

1.72

2.18

1.8

1.5

—

(40768795) Lymph node Pathology biopsy report

126

972

1.30

2.17

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

427

1.45

2.14

1.8

1.7

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

166

1.75

2.14

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

266

1.58

2.13

1.8

1.7

—

(3014271) Vancomycin [Susceptibility]

354

1.50

2.13

3.0

2.9

—

(3026250) Tacrolimus [Mass/volume] in Blood

536

1.40

2.12

44.5

35.9

ug/l

7.1

7.3

0.53

497

(3033942) Copper [Moles/time] in 24 hour Urine

2.36

2.11

1.0

1.3

umol/24h

0.2

0.9

—

(3004451) EKG impression Narrative

373

1.48

2.06

1.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

146

1.78

2.05

7.8

8.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

184

1.69

2.03

2.8

2.6

mmol/l

1.2

1.5

0.45

135

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

449

1.43

2.02

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

223

1.62

2.01

6.7

6.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

110

843

1.31

2.01

2.6

2.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

182

1484

1.23

2.00

1.2

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

385

1.46

1.98

3.0

2.7

—

(3041806) Other cells [#/volume] in Blood by Manual count

835

0.71

1.96

1.6

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

108

830

1.30

1.95

1.3

1.4

e6/l

123029.2

87393.5

0.21

577

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

709

1.33

1.93

1.1

u/l

1.0

1.1

0.15

311

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

704

1.32

1.88

1.4

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

373

1.45

1.88

1.9

1.8

au/ml

281.3

140.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

121

1.82

1.87

2.9

2.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

688

1.32

1.86

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

421

4765

0.88

1.85

1.4

—

(3047189) Immunofixation for 24 hour Urine

351

1.45

1.81

2.3

1.7

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.12

1.81

1.4

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

192

1595

1.21

1.79

2.4

2.5

—

(3051593) INR in Capillary blood by Coagulation assay

312

1.48

1.77

2.5

10.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

583

1.34

1.74

1.9

2.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

110

1.82

1.72

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

314

1.47

1.72

1.1

u/ml

48.7

56.4

0.43

304

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

118

1.78

1.69

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

141

1.70

1.67

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

164

1.65

1.67

1.3

1.6

ng/l

110.6

67.1

0.41

(3040893) Potassium [Moles/volume] in Capillary blood

2.58

1.65

1.4

3.0

mmol/l

4.3

4.5

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

180

1.61

1.65

1.1

1.3

titre

32.2

102.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

606

1.32

1.65

1.2

1.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.89

1.64

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

397

4468

0.89

1.64

1.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

703

1.30

1.63

2.0

1.9

u/field

2.4

1.8

0.43

324

(3028433) Virus identified in Specimen by Culture

368

1.41

1.63

1.1

1.2

—

(3017704) Immunofixation for Urine

402

1.39

1.62

1.7

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

437

1.37

1.60

1.2

1.1

ng/l

66.4

442.0

1.07

102

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

569

1.32

1.55

1.3

1.2

u/l

15.8

20.0

0.73

487

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.11

1.54

1.3

1.4

nmol/l

39.5

22.5

0.54

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

518

1.33

1.53

2.8

2.9

au/ml

209.3

130.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

153

1.64

1.52

1.0

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

650

1.29

1.51

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

695

1.28

1.50

1.7

1.8

mg/l

3.1

3.8

1.35

667

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

186

1.56

1.47

1.1

1.2

mg/l

0.6

72.3

1.20

134

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.81

1.47

2.9

2.1

u/field

0.8

0.7

0.09

(3034614) HLA Ag [Interpretation]

2.50

1.45

1.1

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

179

1.57

1.45

1.6

1.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

594

1.30

1.43

1.3

1.2

u/l

71.7

85.4

1.27

521

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

549

5003

1.10

1.43

2.0

1.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

278

1.44

1.41

1.2

1.1

—

(40762814) Titanium [Mass/volume] in Blood

111

1.71

1.38

2.5

2.3

ug/l

3.0

4.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

230

1.48

1.38

1.2

pmol/l

316.5

312.3

0.02

169

(40757494) Bilirubin.total [Moles/volume] in Blood

502

1.32

1.37

2.7

2.3

umol/l

15.9

55.0

3.64

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.20

1.36

14.7

8.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

174

1.55

1.36

1.1

1.2

ug/l

40.0

352.9

1.23

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

112

1.70

1.35

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

120

1.67

1.33

1.2

1.3

—

(3001556) Androgen free Index in Serum or Plasma

192

1.51

1.31

1.3

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

1.81

1.31

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.76

1.28

1.1

1.3

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

1.88

1.28

1.5

1.9

46.5

62.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

335

1.37

1.28

1.6

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

294

1.40

1.25

1.8

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

303

1.39

1.24

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

450

1.31

1.23

2.2

5.9

mg/l

79.4

904.0

0.76

330

(44806420)

179

1.51

1.23

2.8

2.2

—

(3006462) Nitrate [Presence] in Urine

494

1.30

1.23

2.5

2.9

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.63

1.21

1.2

1.5

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

2.63

1.21

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

196

1.48

1.21

1.6

1.5

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.72

1.20

1.1

—

2.0

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

101

1.68

1.19

1.0

1.1

u/ml

46.5

33.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

247

1.42

1.18

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

131

1102

1.19

1.17

3.8

4.7

u/ml

43.0

88.0

1.72

351

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

528

4859

1.09

1.17

1.6

1.7

mg/l

4.4

3.6

1.08

388

3318

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

1.93

1.16

1.2

1.7

37.4

18.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

507

1.28

1.16

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.77

1.16

1.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.00

1.16

1.2

2.3

—

(3033799) Differential panel - Peritoneal fluid

257

1.40

1.15

2.1

2.0

—

(3035933) Granulocytes/100 leukocytes in Blood

412

1.31

1.14

1.4

1.9

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

430

1.30

1.13

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

652

1.24

1.13

1.1

miu/ml

1424.3

1496.4

0.25

652

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.33

1.12

1.1

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

586

0.75

1.12

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.90

1.12

3.0

5.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.71

1.11

1.0

1.1

—

(3024932) HLA-DR beta [Type]

388

1.32

1.11

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.26

1.10

6.9

8.5

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.26

1.10

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

251

1.40

1.10

1.2

1.1

—

(3025130) Human papilloma virus identified in Specimen

221

1950

1.14

1.09

1.7

1.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

109

912

1.20

1.06

1.3

pmol/l

76.4

98.8

0.26

261

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

635

5916

1.08

1.06

2.8

3.1

u/ml

33.6

44.4

1.70

613

5718

(3036670) Protein [Mass/volume] in Synovial fluid

245

1.39

1.05

1.1

1.2

g/l

38.4

39.1

0.09

130

(3007919) Fasciola sp Ab [Titer] in Serum

2.27

1.03

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.96

1.03

6.7

7.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.83

1.02

3.5

3.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

117

1377

0.85

1.01

1.4

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

282

2541

1.11

1.00

1.8

—

(3024471) HLA-A [Type]

395

1.29

1.00

1.0

—

(3002619) Bacteria identified in Specimen by Culture

222

1.40

1.00

1.3

1.2

—

(4146454)

101

846

1.20

0.99

2.7

2.8

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

159

0.57

0.98

6.9

6.4

73.6

71.0

—

129

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.95

0.0

1.2

—

3737.1

—

(40757373) Influenza virus identified in Isolate

174

1.44

0.94

1.8

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1398

13398

1.05

0.94

2.7

2.8

ug/l

0.6

0.7

3.71

875

8177

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.77

0.94

8.1

4.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.77

0.94

1.5

1.6

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.89

0.94

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

133

1.50

0.94

1.5

1.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

109

1.56

0.93

2.3

3.7

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.82

0.92

1.2

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.14

0.91

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

100

845

1.18

0.91

3.0

2.9

mg/l

44.8

55.9

0.30

620

(3048879) Bone marrow aspiration report

210

1.38

0.90

2.4

2.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

279

1.33

0.89

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

528

1.23

0.89

2.5

2.4

umol/l

51.2

52.1

0.07

459

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

628

1.21

0.88

2.3

2.8

41.9

41.2

0.08

218

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.69

0.88

4.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

502

1.24

0.87

1.0

ng/l

792.3

748.8

0.36

347

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.00

0.87

1.5

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

161

1.43

0.86

1.0

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

119

1027

1.16

0.85

1.2

u/l

56.0

67.3

1.19

689

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

505

1.23

0.84

1.0

ng/l

43.7

43.8

0.01

354

(3035880) pH of Pleural fluid

371

1.27

0.83

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

301

1.30

0.82

1.2

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

206

1851

1.11

0.82

1.4

mmol/l

7.2

6.9

0.75

150

1345

(3049242) von Willebrand panel - Platelet poor plasma

1.88

0.81

1.3

1.7

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

197

1.37

0.81

1.9

4.4

u/l

68.7

74.7

—

(4211845)

535

1.22

0.81

2.5

2.8

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.70

0.80

1.6

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

223

2465

0.90

0.80

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

499

1.22

0.80

1.0

ng/l

314.4

321.8

0.08

357

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

529

1.21

0.77

1.2

—

(3019174) dRVVT (LA screen)

123

1.46

0.77

1.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

174

1.38

0.76

1.2

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

107

1.50

0.76

1.6

1.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

558

1.20

0.75

3.5

mg/l

7.9

8.0

0.07

450

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

141

1.42

0.74

1.2

1.4

56.2

62.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

351

1.25

0.74

3.1

3.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

125

1.44

0.72

1.7

1.6

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.61

0.72

1.1

mmol/l

7.8

8.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.67

0.72

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

317

1.26

0.71

1.8

1.7

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1011

0.86

0.71

1.5

1.4

nmol/l

36.6

31.0

0.70

924

(3006270) Folate [Moles/volume] in Blood

793

1.16

0.71

1.1

nmol/l

364.0

385.5

0.53

701

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.58

0.71

1.9

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

231

2528

0.91

0.71

1.3

ug/l

3.6

3.8

0.15

213

2319

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

151

1.39

0.71

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

267

2454

1.09

0.70

1.5

nmol/l

0.5

0.4

0.17

188

1980

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.92

0.70

2.8

5.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

300

1.27

0.70

1.2

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

408

1.23

0.70

4.5

3.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

212

1.32

0.70

1.4

1.5

g/l

12.5

13.3

0.14

159

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

731

1.16

0.68

1.3

1.5

mmol/l

5.5

0.01

690

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

155

1389

1.12

0.68

1.5

1.3

u/l

39.4

34.1

0.14

135

1209

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.59

0.68

4.9

4.5

—

(3051101) Glucose [Moles/volume] in Cord blood

127

1.42

0.67

5.2

6.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1897

18447

1.03

0.66

3.7

3.8

21.5

21.8

0.34

776

8024

(3025315) Body weight

1.54

0.65

5.1

3.7

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

250

1.28

0.65

1.9

1.5

nmol/l

0.2

0.13

175

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

568

1.18

0.65

1.0

98.9

93.8

0.61

457

(21494434) Karyotype in Bone marrow

735

1.16

0.65

1.2

—

(40768793) Breast Pathology biopsy report

258

2380

1.09

0.64

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

295

1.25

0.64

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.72

0.64

3.8

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

224

0.71

0.63

1.0

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

198

1.31

0.63

2.2

2.4

—

(3020650) Glucose [Presence] in Urine

323

1.24

0.63

1.4

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

190

1.32

0.62

2.1

2.7

mg/l

96.4

29.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.63

0.62

1.0

—

(3013727) Leukocytes other/100 leukocytes in Blood

306

1.24

0.62

5.7

3.7

52.3

50.9

0.16

295

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

114

1.40

0.58

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.56

0.58

1.0

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

219

1.28

0.58

1.2

1.4

mu/l

127.9

99.3

0.14

175

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

446

1.19

0.58

1.2

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

446

1.19

0.58

1.2

1.9

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

255

1.26

0.57

1.4

41.4

63.9

2.47

213

(3029612) Listeria sp Ab [Titer] in Serum

1.71

0.57

1.7

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

755

0.86

0.57

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.48

0.57

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

121

1086

1.12

0.55

1.1

—

(3049233) Organic acids panel - Urine

1.62

0.55

1.2

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.54

0.55

1.0

—

(44806071)

177

1.30

0.54

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.49

0.53

1.0

1.1

u/l

8.0

12.9

0.54

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.45

0.53

5.8

1.9

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.45

0.53

1.7

2.8

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

205

1.27

0.52

2.1

1.6

ug/l

0.4

0.08

137

(3010375) cycloSPORINE [Mass/volume] in Blood

527

1.16

0.51

25.0

27.0

ug/l

139.3

120.4

0.99

438

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

233

1.25

0.50

1.1

1.3

39.4

39.0

0.01

156

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

173

1592

1.09

0.50

3.8

3.6

u/ml

35.3

27.7

0.36

165

1538

(3013762) Body weight Measured

1.46

0.50

1.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

118

1.36

0.50

2.9

3.4

11.2

6.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

136

1.32

0.49

2.1

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

520

1.15

0.49

3.2

3.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.56

0.48

1.4

1.3

nmol/l

291.2

527.3

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.56

0.48

1.0

1.1

mg/l

0.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

962

9930

0.97

0.47

1.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.46

0.46

2.1

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

230

2150

1.07

0.46

4.2

3.2

mg/l

20.9

26.6

2.16

140

1328

(3039443) Prostate specific Ag panel - Serum or Plasma

149

1619

0.92

0.46

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

109

989

1.10

0.44

1.5

1.9

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.41

0.43

8.3

4.8

—

(3037556) Urate [Mass/volume] in Serum or Plasma

248

1.21

0.42

1.3

—

(3044007) Cell count panel - Peritoneal fluid

239

1.21

0.42

2.4

2.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

622

1.13

0.42

1.7

1.6

u/l

6.4

4.7

0.41

298

(3001893) Eosinophils/100 leukocytes in Pleural fluid

212

1.23

0.42

1.4

1.5

2.0

2.4

0.27

182

(40768800) Prostate Pathology biopsy report

116

1267

0.91

0.41

1.2

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

2.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

222

1.22

0.40

1.2

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.33

0.40

1.0

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.0

—

11009.3

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

1.43

0.39

1.2

1.1

pmol/l

347.2

386.8

—

(3046861) Legionella sp Ag [Presence] in Urine

1.43

0.39

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.39

0.0

2.3

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.39

0.0

1.1

—

0.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

115

1.30

0.38

1.4

1.5

20.8

9.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

133

1.28

0.38

2.6

1.9

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

160

1.25

0.38

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

419

1.15

0.38

1.3

1.5

pmol/l

14.2

14.7

0.31

354

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.39

0.38

1.6

1.2

nmol/l

258.8

299.8

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.34

0.38

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

215

1.21

0.38

9.0

7.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

483

0.87

0.37

1.2

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.35

0.37

3.2

2.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

1.31

0.37

1.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.39

0.36

1.8

1.5

umol/24h

387.3

322.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.36

0.34

1.2

1.3

—

(3045462) Protein/Creatinine [Ratio] in Urine

189

0.79

0.34

4.3

4.7

g/mol

29.0

316.9

0.58

170

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

118

1.27

0.33

1.3

1.4

nmol/l

24.0

15.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.28

0.32

1.7

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.35

0.32

1.0

1.1

mg/l

11.3

10.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

156

1.22

0.31

4.9

5.1

ug/min

46.0

39.2

0.23

113

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.27

0.30

16.3

6.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.25

0.29

1.3

2.4

—

(3015183) Erythrocyte sedimentation rate

688

1.09

0.29

1.3

1.2

—

(3022475) Manganese [Moles/volume] in Blood

1.32

0.28

1.2

1.3

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

270

1.15

0.28

1.1

1.4

44.4

53.0

0.51

227

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1163

11412

1.02

0.28

7.7

6.0

—

(3006598) pH of Arterial cord blood

194

0.82

0.27

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

157

1492

1.05

0.24

1.6

mmol/l

7.8

7.6

0.39

104

906

(3034092) Cytoplasmic Ig cells/100 cells in Blood

159

0.82

0.24

8.2

7.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

142

1.20

0.24

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

158

1505

1.05

0.23

1.2

1.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.32

0.23

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

106

1.23

0.23

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

237

1.14

0.23

8.7

6.9

—

(40758358) Immune stain study

1.28

0.23

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

671

1.07

0.21

5.4

6.7

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.21

0.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.22

0.21

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

730

7440

0.98

0.20

1.7

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

563

5516

1.02

0.19

1.4

1.5

—

(3000285) Sodium [Moles/volume] in Blood

109

1.19

0.18

1.2

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

560

0.93

0.18

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

498

0.92

0.18

1.1

u/l

120.5

84.4

0.96

397

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.74

0.17

1.4

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.71

0.16

1.6

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

495

0.93

0.16

1.1

u/l

51.5

22.2

0.70

380

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.16

0.16

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

525

5153

1.02

0.16

1.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

149

1.14

0.15

3.4

3.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

525

5157

1.02

0.15

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

404

4123

0.98

0.15

1.4

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

278

2716

1.02

0.14

1.4

pmol/l

89.1

121.4

1.47

270

2646

(3016273) Islet cell 512 Ab [Units/volume] in Serum

122

1.15

0.13

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

122

1.15

0.13

6.9

3.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.82

0.13

1.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

523

5146

1.02

0.13

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

277

1.08

0.12

1.1

1.2

—

(3034426) Prothrombin time (PT)

433

1.06

0.12

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

127

0.87

0.12

1.2

3.8

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

415

4220

0.98

0.12

1.4

1.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

435

0.94

0.11

6.9

6.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

435

0.94

0.11

3.5

3.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

192

1.09

0.10

1.9

2.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

167

0.90

0.10

1.2

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

455

4487

1.01

0.10

1.5

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

300

1.07

0.10

2.3

2.2

e6/l

1151.0

3528.5

0.43

207

(3005033) Fetal Nuchal fold Thickness US

405

4108

0.99

0.10

1.4

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

269

0.93

0.10

2.6

1.9

e6/l

10791.9

16139.6

0.19

146

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

519

5127

1.01

0.09

1.4

—

(40765096) Chromosome analysis panel by Banding

262

1.07

0.09

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

165

1.09

0.08

3.2

3.0

u/l

360.7

2957.2

1.82

152

(3022670) pH of Venous cord blood

0.82

0.08

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

234

1.07

0.08

2.4

2.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.03

0.07

1.0

1.3

—

(3001729) Color of Synovial fluid

0.80

0.07

1.0

1.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.05

0.07

1.3

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

143

0.91

0.07

1.0

1.1

—

(4281824)

111

1084

1.02

0.07

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.89

0.06

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

152

0.92

0.06

3.9

1.2

mmol/l

8.4

7.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

168

1.07

0.06

1.4

1.3

—

(4133840)

323

0.96

0.05

1.1

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

534

0.97

0.04

7.0

6.3

u/ml

490.6

6422.8

0.53

112

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

240

0.96

0.03

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

151

1.06

0.03

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

330

1.03

0.03

2.1

2.3

ng/l

127.0

119.4

0.13

202

(4038314)

118

0.93

0.02

1.3

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

182

1.04

0.02

2.2

mmol/l

7.7

7.4

0.14

100

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

222

1.04

0.02

1.5

1.8

ug/l

2.1

3.4

0.48

127

(40758292) HTLV I+II Ab panel - Serum

207

0.97

0.01

1.5

1.3

—

(3022689) Creatine [Moles/volume] in Urine

277

0.97

0.01

1.6

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

106

1.04

0.00

1.2

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

114

0.96

0.00

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

155

1.03

0.00

6.3

7.4

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

318

1.01

0.00

1.9

1.7

—

485.0

—

(3026470) Cobalt [Mass/volume] in Blood

441

1.00

0.00

2.0

ug/l

1.3

3.7

6.19

383

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

149

1.01

0.00

1.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.2

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.0

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

7.7

—

12.7

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.3

—

23.3

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.97

0.00

2.2

3.1

—

0.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

21.1

—

(3030703) Everolimus [Mass/volume] in Blood

0.00

0.0

15.2

—

6.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

400

1.00

0.00

1.3

1.2

—

(4212803)

0.97

0.00

1.0

1.1

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

1.8

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.0

2.0

—

(3025577) Chromium [Mass/volume] in Blood

430

1.00

0.00

2.0

2.1

ug/l

1.3

2.6

3.87

366

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

32.8

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

0.98

0.00

1.3

1.4

54.9

72.3

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES – Other and unspecified effects of external causes

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other and unspecified effects of external causes

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other and unspecified effects of external causes (ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints